CN109843380A - The copolymer compositions applied for coating and adhesive - Google Patents

The copolymer compositions applied for coating and adhesive Download PDF

Info

Publication number
CN109843380A
CN109843380A CN201780064745.6A CN201780064745A CN109843380A CN 109843380 A CN109843380 A CN 109843380A CN 201780064745 A CN201780064745 A CN 201780064745A CN 109843380 A CN109843380 A CN 109843380A
Authority
CN
China
Prior art keywords
subscript
alternatively
adhesive
copolymer
skin contact
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201780064745.6A
Other languages
Chinese (zh)
Other versions
CN109843380B (en
Inventor
朱弼忠
M·格拉斯曼
V·潘迪特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Corning Canada Inc
Dow Silicones Corp
Original Assignee
Dow Silicones Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Silicones Corp filed Critical Dow Silicones Corp
Publication of CN109843380A publication Critical patent/CN109843380A/en
Application granted granted Critical
Publication of CN109843380B publication Critical patent/CN109843380B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L75/00Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers
    • C08L75/04Polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0246Adhesive plasters or dressings characterised by the skin adhering layer
    • A61F13/0253Adhesive plasters or dressings characterised by the skin adhering layer characterized by the adhesive material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/58Adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043Mixtures of macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/10Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/10Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
    • C08G18/12Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step using two or more compounds having active hydrogen in the first polymerisation step
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08Processes
    • C08G18/16Catalysts
    • C08G18/22Catalysts containing metal compounds
    • C08G18/227Catalysts containing metal compounds of antimony, bismuth or arsenic
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30Low-molecular-weight compounds
    • C08G18/32Polyhydroxy compounds; Polyamines; Hydroxyamines
    • C08G18/3203Polyhydroxy compounds
    • C08G18/3206Polyhydroxy compounds aliphatic
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/48Polyethers
    • C08G18/4833Polyethers containing oxyethylene units
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/61Polysiloxanes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72Polyisocyanates or polyisothiocyanates
    • C08G18/74Polyisocyanates or polyisothiocyanates cyclic
    • C08G18/75Polyisocyanates or polyisothiocyanates cyclic cycloaliphatic
    • C08G18/751Polyisocyanates or polyisothiocyanates cyclic cycloaliphatic containing only one cycloaliphatic ring
    • C08G18/752Polyisocyanates or polyisothiocyanates cyclic cycloaliphatic containing only one cycloaliphatic ring containing at least one isocyanate or isothiocyanate group linked to the cycloaliphatic ring by means of an aliphatic group
    • C08G18/753Polyisocyanates or polyisothiocyanates cyclic cycloaliphatic containing only one cycloaliphatic ring containing at least one isocyanate or isothiocyanate group linked to the cycloaliphatic ring by means of an aliphatic group containing one isocyanate or isothiocyanate group linked to the cycloaliphatic ring by means of an aliphatic group having a primary carbon atom next to the isocyanate or isothiocyanate group
    • C08G18/755Polyisocyanates or polyisothiocyanates cyclic cycloaliphatic containing only one cycloaliphatic ring containing at least one isocyanate or isothiocyanate group linked to the cycloaliphatic ring by means of an aliphatic group containing one isocyanate or isothiocyanate group linked to the cycloaliphatic ring by means of an aliphatic group having a primary carbon atom next to the isocyanate or isothiocyanate group and at least one isocyanate or isothiocyanate group linked to a secondary carbon atom of the cycloaliphatic ring, e.g. isophorone diisocyanate
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72Polyisocyanates or polyisothiocyanates
    • C08G18/74Polyisocyanates or polyisothiocyanates cyclic
    • C08G18/76Polyisocyanates or polyisothiocyanates cyclic aromatic
    • C08G18/7614Polyisocyanates or polyisothiocyanates cyclic aromatic containing only one aromatic ring
    • C08G18/7621Polyisocyanates or polyisothiocyanates cyclic aromatic containing only one aromatic ring being toluene diisocyanate including isomer mixtures
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L75/00Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers
    • C08L75/04Polyurethanes
    • C08L75/06Polyurethanes from polyesters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/04Polysiloxanes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D175/00Coating compositions based on polyureas or polyurethanes; Coating compositions based on derivatives of such polymers
    • C09D175/04Polyurethanes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D175/00Coating compositions based on polyureas or polyurethanes; Coating compositions based on derivatives of such polymers
    • C09D175/04Polyurethanes
    • C09D175/06Polyurethanes from polyesters
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D183/00Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers
    • C09D183/04Polysiloxanes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D7/00Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
    • C09D7/40Additives
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09JADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J175/00Adhesives based on polyureas or polyurethanes; Adhesives based on derivatives of such polymers
    • C09J175/04Polyurethanes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09JADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J175/00Adhesives based on polyureas or polyurethanes; Adhesives based on derivatives of such polymers
    • C09J175/04Polyurethanes
    • C09J175/06Polyurethanes from polyesters
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09JADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
    • C09J183/00Adhesives based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Adhesives based on derivatives of such polymers
    • C09J183/04Polysiloxanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00655Plasters adhesive
    • A61F2013/00659Plasters adhesive polymeric base

Abstract

The invention discloses a kind of organic-siloxane copolymer composition, the organic-siloxane copolymer composition can be used for preparing skin contact adhesive or coating.Skin contact adhesive composition include (I) it is organic-siloxane copolymer composition and (II) excipient.Skin contact adhesive by hardening composition preparation can be used for using such as the adhesive of medical adhesive tape, the adhesive for wound dressing, the adhesive for prosthese, ostomy appliance adhesive, for the adhesive of medical monitor tool, for the adhesive of scar therapy treatment, for the adhesive and transdermal drug delivery systems of cosmetics drug paste.Coating composition include (a) it is organic-siloxane copolymer composition and (b) coating additive.The coating by hardening the coating composition preparation can be used for handling leather.

Description

The copolymer compositions applied for coating and adhesive
The cross reference of related application
The U.S. Provisional Patent Application Serial No. 62/396336 that patent application claims September in 2016 is submitted on the 19th it is excellent First weigh.The U.S. Provisional Patent Application of Serial No. 62/396336 is incorporated by reference accordingly.
Background technique
Technical field
Copolymer compositions can be used for preparing skin contact adhesive and/or coating in substrate.It discloses preparation and makes With the method for copolymer compositions.Copolymer compositions include organosiloxane copolymer.
Brief introduction
Various types of skin contact adhesives have been proposed for skin contact application such as medical adhesive tape Adhesive, the adhesive for prosthese, ostomy appliance adhesive, is used for medical monitor at the adhesive for wound dressing The adhesive of tool, for scar therapy treatment adhesive and transdermal drug delivery systems.Aqueous colloidal adhesive and propylene Acid esters adhesive usually has highest adhesion strength (for example, it is desired to ceiling capacity to remove from skin).Polyurethane binder With the second high adhesion strength, and siloxanes has the minimum adhesion strength of the skin contact adhesive of these types.With need It those of to remove adhesive compared with low energy to compare, there are skin contact adhesives of higher adhesion strength (to need higher for those Energy removes) during removal in may cause bigger pain and wound may be caused to skin.Certain skins connect Touching adhesive is also possible to leave unexpected residue on the skin during removal.
During chronic wound care, adhesiveness wound dressing and/or medical adhesive tape may during more change dressings In wound and cause pain and damage at wound circumference.Repeatedly apply and remove skin contact adhesive may bring pain and Wound, for the patient with delicate skin.Delicate skin is usually characterized by that skin is thin and is easy to tear, And it is more common in the elderly compared to other crowds.Aging, light exposure and heredity are the factor for causing thinning of skin. Some drugs (oral or topical corticosteroid is such as used for a long time) are it is also possible that the blood vessel in skin and skin becomes crisp It is weak, and make it easier to by wound associated with adhesive is removed.Individual with delicate skin can also occur in The situation that cohesive force between epidermis and corium and between corium and subcutaneous tissue is lost, this is easier these individuals There is a situation where skin lacerations and wound, especially when using the skin contact adhesive with higher adhesion strength.
In addition, silicone adhesive (for example, by two parts those of silicone elastomer preparation of catalysis) may be uncomfortable Such as transdermal drug delivery is applied for certain skin contact adhesives.It is used to prepare certain catalyst of silicone elastomer (such as, for the platinum metal catalysts of Si―H addition reaction) may negatively affect the medicinal actives in transdermal drug delivery device Ingredient.
In addition to skin contact adhesive, polyurethane and polysiloxane are also used for the painting being applied in various substrates Material.Known polyurethane has high mechanical tenacity, but has some defects, and such as temperature tolerance, moisture-proof and irradiation stability are limited. Polysiloxane is highly stable at ambient conditions.Some polysiloxane are incorporated into the coating based on polyurethane There are challenges in industry, because the chemical property of polysiloxane and polyurethane makes it have the compatibility being very limited.
Problem to be solved
Industry, which needs to develop, can be used for being formed the skin contact adhesive with one or more of following benefit Composition: good bond properties, the ability (for example, transdermal drug delivery application in) of transfer activity ingredient, moisture-proof (from Environment is to skin), conveying of the water from skin to environment, stability, minimum skin irritatin, during using and removing to skin Damage it is minimum and/or residue during removal and after removing on skin is minimum.Industry also needs to develop one kind The composition that can be used for being formed on the substrate coating, with one or more of following benefit: in polyurethane and silicon oxygen Improved compatibility, improved weatherability, hydrophobicity, hydrolytic stability, radiation resistance, heat resistance, corrosion resistance between alkane, Surface smoothness and gloss, scratch resistance, under similar solid content relatively low viscosity (influence volatile organic content, VOC) and friction reduces.
Summary of the invention
Copolymer compositions include two or more initial substances.Copolymer compositions include copolymer (A) and are copolymerized At least one of object (B), wherein copolymer (A) is organic-silicone copolymers of the unit comprising following formula:
Wherein
Each RDIt independently is divalent hydrocarbyl mission or divalent halogenated hydrocarbon group;
Each RMIt independently is monovalent hydrocarbon radical or monovalence halogenated hydrocarbon group;
Each RTIt independently is hydrogen or hydrocarbyl group;
Each subscript b is independently 0 to 1,000,000;
Subscript c be 0 to 200,000, subscript i be 0 to 200,000, subscript w1 be 0 to 200,000, subscript w2 be 0 to 200,000, subscript w3 are 0 to 200,000, and subscript w4 is 0 to 200,000, and quantity (c+i+w1+w2+w3+w4) >=1;
Subscript d is 0 to 1,000,000;
Subscript e is 0 to 1,000,000;
Subscript f is 0 to 1,500,000;
Subscript h >=0;
Subscript j1 >=0;
Each X independently is nitrogen, oxygen or sulphur;
When X is oxygen or sulphur, subscript o=0, and when X is nitrogen, subscript o=1;
Subscript r is 0 to 1,500,000, and quantity f+r >=1;
Subscript s is 0 to 200,000;And
Subscript v is 0 to 200,000;
Subscript y is >=0;
And copolymer (B) is organic-silicone copolymers of the unit comprising following formula:
Wherein RT、RD、RMAnd subscript o, l, s, v, r, c, I, w1, w2, w3, w4, b and y are such as above with respect to copolymer (A) it is defined, and subscript j2 > 0, and if j1 > 0, j2/j1 >=1.1.Copolymer (A) and copolymer (B) are each other not Together.The blend also may include one or both of following substance:
(C) organic polyhydric alcohol;Or
(D) reaction product of organic multiple isocyanate and organic polyhydric alcohol.
Skin contact adhesive composition includes above-mentioned copolymer compositions, and skin contact adhesive composition hardens To form skin contact adhesive.Skin contact adhesive can be used in various skin contact adhesive applications, comprising: for curing With the adhesive of adhesive tape, the adhesive for wound dressing, the adhesive for prosthese, ostomy appliance adhesive, for curing With monitoring utensil adhesive, for scar therapy treatment adhesive, for the adhesive and transdermal medicine of cosmetics drug paste Object delivery system.
Coating composition includes above-mentioned copolymer compositions.Coating composition can be applied in various substrates, and can Coating is formed on the substrate to harden.
Detailed description of the invention
Fig. 1 be include skin contact adhesive as described herein laminate 100 partial cross-section.
The wound that Fig. 2A shows 200 form of adhesive bandage including skin contact adhesive 202 as described herein applies The perspective view of material.
Fig. 3 shows the wound dressing of 300 form of laminate including skin contact adhesive 308 as described herein Partial cross-section.
It is including flange used in the ostomy appliance of skin contact adhesive 402 as described herein that Fig. 4, which is shown, 400。
Appended drawing reference
The opposite surface of 100 laminate, 303 supporter
101 supporter, 304 supporter
The surface towards skin of 102 skin contact adhesive, 305 supporter
103 release liner, 306 absorbed layer
The opposite surface of 104 307 skin contact adhesives of surface towards skin
308 skin contact adhesive of surface of 105 contact skins
The surface towards skin of 200 adhesive bandage, 309 skin contact adhesive
201 absorbed layer, 310 release liner
202 skin contact adhesive, 400 flange
203 401 supporting members of surface towards skin
204 supporter, 402 skin contact adhesive
205 skin contact surface, 403 hole
300 laminates
The opposite surface of 301 carriers
302 carriers
Specific embodiment
Copolymer compositions include at least one of copolymer (A) and copolymer (B).The copolymer compositions can be optional Ground also includes one or both of following substance: initial substance (C): organic polyhydric alcohol;And initial substance (D): You Jiduo The reaction product of isocyanates and organic polyhydric alcohol.The copolymer compositions include at least two initial substances.The copolymer group Closing object may include (A) and (B).Alternatively, the copolymer compositions may include (A) and (C).Alternatively, the copolymer compositions can wrap Containing (B) and (C).Alternatively, the copolymer compositions may include (A) and (D).Alternatively, the copolymer compositions may include (B) and (D).Alternatively, the copolymer compositions may include (A), (B) and (C).Alternatively, the copolymer compositions may include (A), (B) and (D).Alternatively, the copolymer compositions may include (A), (C) and (D).Alternatively, the copolymer compositions may include (B), (C) and (D).Alternatively, the copolymer compositions may include (A), (B), (C) and (D).
Copolymer (A)
Copolymer (A) is organic-silicone copolymers.Copolymer (A) includes the unit of following formula:
In said units formula, each RDIt independently is divalent hydrocarbyl mission or divalent halogenated hydrocarbon group, as defined below. Each RDCan independently have 2 to 13 carbon atoms.Alternatively, each RDIt can be selected from alkylidene such as ethylidene or propylidene, sub- virtue Base such as phenylene or sub- aralkyl.Alternatively, each RDIt can be alkylidene group, such as ethylidene or propylidene.
Each RMIt independently is monovalent hydrocarbon radical or monovalence halogenated hydrocarbon group, as defined below.Each RMCan have 1 to 13 carbon atoms.Alternatively, each RMIt can be the monovalent hydrocarbon radical without aliphatic degree of unsaturation.For example, each RMIt can be independently selected from Alkyl, such as methyl, ethyl, propyl, butyl or hexyl;Aryl such as phenyl or aralkyl such as tolyl, xylyl or Phenyl methyl.Alternatively, each RMIt can be methyl or phenyl, and each RMIt can be methyl.
Each RTFor hydrogen or monovalent hydrocarbon radical.RTMonovalent hydrocarbon radical can have 1 to 13 carbon atom.RTMonovalent hydrocarbon Group is independently selected from alkyl, such as methyl, ethyl, propyl, butyl or hexyl;Aryl, such as phenyl;Or aralkyl, such as first The group of phenyl, xylyl or phenyl methyl.Alternatively, each RTIt can be methyl or phenyl.Alternatively, each RTIt can be hydrogen or first Base.
Each subscript b is independently greater than or is equal to 0.Each example of subscript b can have in the different units of copolymer Different value.Alternatively, subscript b is 0 to 1,000,000.Alternatively, subscript b is 0 to 200,000.Alternatively, subscript b is 0 to 100, 000.Alternatively, subscript b is 0 to 50,000.Alternatively, subscript b is 0 to 10,000.Alternatively, subscript b is 0 to 5,000.Under alternatively, Marking b is 0 to 1,000.Alternatively, subscript b is 0 to 500.Alternatively, subscript b is 0 to 100.Alternatively, subscript b is 1 to 100.Alternatively, Subscript b is 1 to 50.Alternatively, subscript b is 1 to 20.Alternatively, subscript b is 0 to 1.Alternatively, subscript b=1.Alternatively, subscript b=2. Alternatively, subscript b=3.Alternatively, subscript b=4.Alternatively, subscript b=5.
Subscript c >=0.Alternatively, subscript c is 0 to 200,000.Alternatively, subscript c is 0 to 100,000.Alternatively, subscript c is 0 To 50,000.Alternatively, subscript c is 0 to 10,000.Alternatively, subscript c is 0 to 5,000.Alternatively, subscript c is 0 to 1,000.Or Person, subscript c are 0 to 500.Alternatively, subscript c is 0 to 100.Alternatively, subscript c is 0 to 50.Alternatively, subscript c is 0 to 20.Alternatively, Subscript c is 0 to 10.Alternatively, subscript c is 1 to 100.Alternatively, subscript c is 1 to 50.Alternatively, subscript c is 1 to 20.Alternatively, subscript C is 1 to 10.
Subscript i >=0.Alternatively, subscript i is 0 to 200,000.Alternatively, subscript i is 0 to 100,000.Alternatively, subscript i is 0 To 50,000.Alternatively, subscript i is 0 to 10,000.Alternatively, subscript i is 0 to 5,000.Alternatively, subscript i is 0 to 1,000.Or Person, subscript i are 0 to 500.Alternatively, subscript i is 0 to 100.Alternatively, subscript i is 0 to 50.Alternatively, subscript i is 0 to 20.Alternatively, Subscript i is 0 to 10.Alternatively, subscript i is 1 to 100.Alternatively, subscript i is 1 to 50.Alternatively, subscript i is 1 to 20.Alternatively, subscript I is 1 to 10.
Subscript w1 >=0.Alternatively, subscript w1 is 0 to 200,000.Alternatively, subscript w1 is 0 to 50,000.Alternatively, subscript w1 It is 0 to 10,000.Alternatively, subscript w1 is 0 to 5,000.Alternatively, subscript w1 is 0 to 1,000.Alternatively, subscript w1 is 0 to 500. Alternatively, subscript w1 is 0 to 100.Alternatively, subscript w1 is 0 to 50.Alternatively, subscript w1 is 0 to 20.Alternatively, subscript w1 is 0 to 10. Alternatively, subscript w1 is 1 to 100.Alternatively, subscript w1 is 1 to 50.Alternatively, subscript w1 is 1 to 20.Alternatively, subscript w1 is 1 to 10.
Subscript w2 >=0.Alternatively, subscript w2 is 0 to 200,000.Alternatively, subscript w2 is 0 to 50,000.Alternatively, subscript w2 It is 0 to 10,000.Alternatively, subscript w2 is 0 to 5,000.Alternatively, subscript w2 is 0 to 1,000.Alternatively, subscript w2 is 0 to 500. Alternatively, subscript w2 is 0 to 100.Alternatively, subscript w2 is 0 to 50.Alternatively, subscript w2 is 0 to 20.Alternatively, subscript w2 is 0 to 10. Alternatively, subscript w2 is 1 to 100.Alternatively, subscript w2 is 1 to 50.Alternatively, subscript w2 is 1 to 20.Alternatively, subscript w2 is 1 to 10.
Subscript w3 >=0.Alternatively, subscript w3 is 0 to 200,000.Alternatively, subscript w3 is 0 to 50,000.Alternatively, subscript w3 It is 0 to 10,000.Alternatively, subscript w3 is 0 to 5,000.Alternatively, subscript w3 is 0 to 1,000.Alternatively, subscript w3 is 0 to 500. Alternatively, subscript w3 is 0 to 100.Alternatively, subscript w3 is 0 to 50.Alternatively, subscript w3 is 0 to 20.Alternatively, subscript w3 is 0 to 10. Alternatively, subscript w3 is 1 to 100.Alternatively, subscript w3 is 1 to 50.Alternatively, subscript w3 is 1 to 20.Alternatively, subscript w3 is 1 to 10.
Subscript w4 >=0.Alternatively, subscript w4 is 0 to 200,000.Alternatively, subscript w4 is 0 to 50,000.Alternatively, subscript w4 It is 0 to 10,000.Alternatively, subscript w4 is 0 to 5,000.Alternatively, subscript w4 is 0 to 1,000.Alternatively, subscript w4 is 0 to 500. Alternatively, subscript w4 is 0 to 100.Alternatively, subscript w4 is 0 to 50.Alternatively, subscript w4 is 0 to 20.Alternatively, subscript w4 is 0 to 10. Alternatively, subscript w4 is 1 to 100.Alternatively, subscript w4 is 1 to 50.Alternatively, subscript w4 is 1 to 20.Alternatively, subscript w4 is 1 to 10.
Quantity (c+i+w1+w2+w3+w4) >=1.Alternatively, in one embodiment, such as when use methanol-functionalization Polysiloxane is come when preparing copolymer, i=w2=w4=0 as described below, and quantity (c+w1+w3) >=1.It is real in substitution It applies in scheme, such as when using amine-functional polysiloxane to prepare copolymer, as described below, c=w1=w3=0, And quantity (i+w1+w3) >=1.
Each X independently is nitrogen (N), oxygen (O) or sulphur (S).Alternatively, x is N or O.Alternatively, each X is N.Alternatively, each X For O.When X is O or S, subscript o=0, and when X is N, subscript o=1.
Subscript d, e and h depend on the molecular weight of a siloxanes segment in copolymer, and can be what there is no limit (for example, only by the constraint of the accessible molecular weight of the prior art of siloxanes synthesis chemical field).However, subscript d can for 0 to 1,000,000;Subscript e can be 0 to 1,000,000;Subscript h can be 0 to 1,000,000, precondition be quantity (d+e+h) >= 1.Subscript d >=0.Alternatively, subscript d > 0.Alternatively, subscript d is 0 to 200,000 or 0 to 100,000 or 0 to 50,000, Or 0 to 10,000 or 0 to 5,000 or 0 to 1,000 or 1 to 1,000 perhaps 1 to 500 and 1 to 200。
Subscript e >=0.Alternatively, subscript e is 0 to 1,000,000.Alternatively, subscript e be 0 to 200,000, and 0 to 100,000 or 0 to 50,000 or 0 to 10,000 or 0 to 5,000 or 0 to 1,000 or 1 to 1,000, or Person 1 to 500, and 1 to 200.Alternatively, subscript e=0.
Subscript f indicates the quantity of carbamate and/or urea unit in copolymer.Subscript f >=0.Alternatively, subscript f be 0 to 1,500,000.Alternatively, subscript f is 1 to 500,000, and 1 to 200,000 or 1 to 50,000 or 1 to 10, 000 or 1 to 5,000 or 1 to 1,000 perhaps 1 to 500 and 1 to 200.
Subscript h >=0.Alternatively, subscript h is 0 to 1,000,000.Alternatively, subscript h be 0 to 200,000, and 0 to 100,000 or 0 to 50,000 or 0 to 10,000 or 0 to 5,000 or 0 to 1,000 or 1 to 1,000, or Person 1 to 500, and 1 to 200.Alternatively, subscript h=0.
Subscript j1 >=0.Alternatively, subscript j1 is > 0 to 500,000.Alternatively, subscript j1 is > 0 to 200,000, and 20 to 100,000 or 50 to 50,000 or 100 to 10,000 or 1,000 to 5,000 or 100 to 1,000, or Person 10 to 500, and 15 to 200.
Subscript s >=0.Alternatively, subscript s is 0 to 200,000.Alternatively, subscript s be 0 to 150,000, and 0 to 100,000 or 0 to 50,000 or 1 to 10,000 or 1 to 5,000 or 1 to 1,000 or 1 to 500, and Or 1 to 200.
Subscript v >=0.Alternatively, subscript v is 0 to 200,000.Alternatively, subscript v be 0 to 150,000, and 0 to 100,000 or 0 to 50,000 or 1 to 10,000 or 1 to 5,000 or 1 to 1,000 or 1 to 500, and Or 1 to 200.
Subscript y >=0.Alternatively, subscript y is 0 to 200,000.Alternatively, subscript y be 0 to 150,000, and 0 to 100,000 or 0 to 50,000 or 1 to 10,000 or 1 to 5,000 or 1 to 1,000 perhaps 1 to 500 or 1 to 200 perhaps 1 to 20 and 1.
Alternatively, copolymer (A) can have unit formula (I) as subscript c=i=w2=w3=w4=e=h=0:
-[-O-RD- OH], wherein RDAnd RMAs described above.Each subscript a is independently 0 to 1,000,000, each subscript m It is independently greater than or equal to 0, each subscript b is independently greater than or is equal to 0, and subscript n is greater than or equal to 1.Alternatively, under each Mark b >=0.Alternatively, subscript b is 0 to 1,000,000.Alternatively, subscript b is 0 to 200,000.Alternatively, subscript b is 0 to 100, 000.Alternatively, subscript b is 0 to 50,000.Alternatively, subscript b is 0 to 10,000.Alternatively, subscript b is 0 to 5,000.Under alternatively, Marking b is 0 to 1,000.Alternatively, subscript b is 0 to 500.Alternatively, subscript b is 0 to 100.Alternatively, subscript b is 1 to 100.Alternatively, Subscript b is 1 to 50.Alternatively, subscript b is 1 to 20.Alternatively, subscript b is 0 to 1.Alternatively, subscript b=0.Alternatively, subscript b=1. Alternatively, subscript b=2.Alternatively, subscript b=3.Alternatively, subscript b=4.Alternatively, subscript b=5.
Alternatively, copolymer (A) can have formula (II):
,
Wherein RDAnd RMAs described above, subscript a is independently 0 to 1,000,000, each subscript b is independently greater than or is equal to 0, and subscript n is greater than or equal to 1.Alternatively, each subscript b >=0.Alternatively, subscript b is 0 to 1,000,000.Alternatively, subscript b It is 0 to 200,000.Alternatively, subscript b is 0 to 100,000.Alternatively, subscript b is 0 to 50,000.Alternatively, subscript b is 0 to 10, 000.Alternatively, subscript b is 0 to 5,000.Alternatively, subscript b is 0 to 1,000.Alternatively, subscript b is 0 to 500.Alternatively, subscript b is 0 to 100.Alternatively, subscript b is 1 to 100.Alternatively, subscript b is 1 to 50.Alternatively, subscript b is 1 to 20.Alternatively, subscript b be 0 to 1.Alternatively, subscript b=0.Alternatively, subscript b=1.Alternatively, subscript b=2.Alternatively, subscript b=3.Alternatively, subscript b=4.Alternatively, Subscript b=5.
Copolymer (B)
Copolymer (B) is siloxanes-carbamate-urea copolymer, and it includes the units of following formula:
Wherein RT、RD、RMAnd subscript o, l, s, v, r, c, i, w1, w2, w3, w4, b and y are such as above with respect to altogether Polymers (A) is defined, and subscript j2 > 0.When copolymer (A) and copolymer (B) are present in copolymer compositions, and And as j1 > 0, then j2/j1 >=1.1.Alternatively, subscript j2 is 1 to 500,000.Alternatively, subscript j2 is 1 to 200,000, or 20 to 100,000 or 50 to 50,000 or 100 to 10,000 or 1,000 to 5,000 or 100 to 1,000, or Person 10 to 500, and 15 to 200.
Alternatively, copolymer (B) can have unit formula (III):
Wherein RD、RM, subscript a, b and n as described above, and subscript n 1 be greater than or equal to 0, or be 0 to 200,000 or 0 To 20,000 or 0 to 10,000 or 0 to 5,000 or 0 to 1,000 perhaps 0 to 100 or 1 to 50.Subscript n 2 0 or 1, and quantity (n2+n3)=1 are respectively with n3.
(C) organic polyhydric alcohol
Initial substance (C) is organic polyhydric alcohol.Suitable organic polyhydric alcohol is containing two or more hydroxyl groups Organic polymer.Organic polyhydric alcohol for initial substance (C) can be polyether polyol, polyester polyol, polyacrylate Polyalcohol, polycaprolactone polyol, polyurethane polyol, polycarbonate polyol, polybutadiene diol, other polymers are polynary Two or more in alcohol or these organic polyhydric alcohols.Also the copolymerization of the polymer of two or more seed types can be used Object polyalcohol.Also can be used on polymer architecture there are other to modify such as fluorinated polyalcohol.Alternatively, suitable organic Polyalcohol can be organic polymer glycol.This organic polymer glycol includes polyoxyalkylene glycol, such as polyoxygenated Ethylidene glycol, oxide glycols and polyoxybutylene glycol;Or polycarbonate glycol.Alternatively, suitable organic Polyalcohol can be small molecule organic diol.This micromolecular organic diol includes glycerol.Organic polyhydric alcohol can be added to adjust The surface energy and/or hydrophily/mechanical performance of copolymer compositions.Additive amount can be 0% to 95% or 0% to 75%, or Person 0% to 50%, and 1% to 25%.
(D) reaction product of organic multiple isocyanate and organic polyhydric alcohol
Initial substance (D) can be by making initial substance (C), and above-mentioned organic polyhydric alcohol is reacted with isocyanate compound to be come Preparation, the isocyanate compound per molecule have average one or more isocyanate groups.Alternatively, organic isocyanate Two or more average isocyanate groups can be had by closing object per molecule.Organic isocyanate compound can have following formula: R- (N=C=O)p, wherein R is hydrocarbyl group or halogenated hydrocarbon group, and subscript p is to indicate isocyanate groups quantity in per molecule Integer, and p be greater than or equal to 1.Alternatively, subscript p is 2,3 or 4;Alternatively, subscript p is 2 or 3;And alternatively, subscript p is 2.When subscript p is 2, R is divalent hydrocarbyl mission.When subscript p is 3, R is trivalent hydrocarbon radical group.When subscript p is 4, R is tetravalence Hydrocarbyl group.
The example of organic isocyanate compound is monomeric diisocyanate and polymeric isocyanate.Monomeric diisocyanate includes Aromatic diisocyanates, such as between tetramethylxylene diisocyanate (TMXDI), toluene di-isocyanate(TDI) (TDI), phenylene Diisocyanate, xylene diisocyanate, 1,5- naphthalene diisocyanate, chlorine phenylene 2,4- diisocyanate, dimethylbenzene two Isocyanates, dianisidine diisocyanate, toluidine diisocyanate and alkylated benzene diisocyanates;It is aliphatic and alicyclic Isocyanates, such as hexamethylene diisocyanate (HDI), hydrogenated methylene diphenyl diisocyanate (HMDI), 1- isocyanide Acidic group -3- isocyanatometyl -3,5,5- trimethyl-cyclohexane (isophorone diisocyanate, IPDI) and three isocyanide of nonyl Acid esters (TTI), the aromatic diisocyanates that methylene interrupts, such as methylene-diphenyl-diisocyanate, especially 4,4'- Isomers (MDI), including alkylated analogs, such as 3,3'- dimethyl -4,4'- diphenyl-methane diisocyanate;Hydrogenation Substance, such as cyclohexylene diisocyanate, 4,4'- methylene biscyclohexyl diisocyanate;Mix aralkyl diisocyanate Ester, such as tetramethyl xylene phenyl diisocyanate, Isosorbide-5-Nitrae-bis- (1- isocyanate group -1,1'- dimethyl methyl) benzene, OCNC (CH3)2C6H4C(CH3)2NCO and polymethylene isocyanates, such as Isosorbide-5-Nitrae-tetramethylene diisocyanate, 1,5-, five methylene Group diisocyanate, 1,6- hexamethylene diisocyanate (HDI), 1,7- heptamethylene diisocyanate, 2,2,4- and 2,4, 4- trimethyl hexamethylene diisocyanate, 1,10- decamethylene diisocyanate and 2- methyl-1, two isocyanide of 5- pentamethylene Acid esters;Vinyl isocyanate;And their combination.
Polymerizeing organic isocyanate includes isocyanate dimerization urea diketone or urea diacetyl and carbodiimide, cyamelide Ester isocyanuric acid ester, imidoyl-oxadiazine-diketone, uretonimine and linear polymer α-nylon;And derivative isocyanic acid Ester to form allophanate or biuretized by reacting Bifunctionalized or multiple functionalized isocyanates with various compounds Close object or isocyanate-functional carbamate or other prepolymers.Some polyisocyanates be it is Bifunctionalized, i.e., every point Son has 2 isocyanate groups.Some isocyanate groups having more than two.Another example is polymeric diphenylmethanes two Isocyanates is, the mixture of the molecule of three and four or more isocyanate groups that be averaged function there are two tools Degree can be greater than two, usually 2.7.Isocyanate functional compound of the isocyanate functionality greater than two may act as crosslink sites. Commercially available isocyanate-functional organic compound is with the Tolonate XIDT 70SB (Rhodia in the New Jersey city Crane Bai Li A kind of isophorone diisocyanate tripolymer (70% solid, 12.3 weights of company (Rhodia, Cranbury, NJ) sale Amount %NCO)) and Desmodur N-100 polyisocyanates (derived from Mobay company) be illustrated.
Alternatively, organic isocyanate compound can be blocked isocyanate.Isocyanate groups can be by common envelope Hold agent (such as, phenol, nonyl phenol, diacetylmonoxime, caprolactam etc.) sealing end.These blocked isocyanates can be at a certain temperature Release, to be reacted with chain extender and polysiloxane, to construct organic-silicone copolymers.End-capping reagent can be by adding Heat is reacted/is discharged to certain temperature.
Reaction product (D) can be low molecular weight compound, or with the prepolymer or macromolecule down to intermediate molecular weight Weight polymers, this degree for depending on isocyanates/OH reactive group molar ratio and being reacted.Organic polyhydric alcohol can have There are relatively large molecular weight and lower glass transition temperatures (Tg) to be formed in the reaction product a part of " soft chain segment ", or With low molecular weight to form " hard segment " in the reaction product.Depending on the molar ratio of polyalcohol and isocyanates and anti- It answers, reaction product (D) can have remaining hydroxyl group or isocyanate groups or isocyanate groups and hydroxyl group two Person, or without remaining reactive group.
Method by initial substance (i.e. the pure and mild polyisocyanates of organic multicomponent) preparation reaction product (D) is known, and And it can be using any conventional method for preparing polyether polyols.Such methods are found in United States Patent (USP) 3,384,623,5, 200,491 and 5,621,024.The method for being used to prepare copolymer (A)
The method that the method for preparing copolymer (A) is similar to preparation reaction product (D).It can be used above-cited with reference to text Method described in offering, but initial substance is become into those described herein substance.
The above-mentioned copolymer as initial substance (A) can be by including prepared by the method for following procedure:
1) make include the following terms initial substance reaction:
A) isocyanate compound,
B) polysiloxane, and
C) chain extender.
In one embodiment, all initial substances can be combined and make its simultaneous reactions.Alternatively, can make comprising a) isocyanide The initial substance of ester compound and b) polysiloxane is reacted to form prepolymer, and then can make prepolymer with comprising C) reaction of the initial substance of chain extender and a) isocyanate compound of optionally other amount is to form copolymer.Alternatively, can Make comprising a) isocyanate compound and c) initial substance of chain extender is reacted to form intermediate, and then can make intermediate It is reacted with the initial substance comprising b) polysiloxane and a) isocyanate compound of optionally other amount to be formed altogether Polymers.
In all these embodiments, no matter polysiloxane wherein reacts, and can use poly organo The mixture of alkane and organic polyhydric alcohol replaces polysiloxane.Alternatively, this method can include: i) make a) isocyanate compound Reacted with b) polysiloxane and d) organic polyhydric alcohol to form prepolymer, and then ii) make prepolymer and c) chain extender A) the isocyanate compound of optionally other amount reacts.
In each embodiment of the above method, initial substance b) polysiloxane can be b1) methanol-functionalization Polysiloxane, b2) amine-functional polysiloxane or b1) and mixture b2).
Initial substance a) isocyanate compound
In the above-mentioned methods, a) isocyanate compound per molecule has average one or more isocyanate groups.Or Person, isocyanate compound per molecule can have two or more average isocyanate groups.Isocyanate compound can have There is following formula: R- (N=C=O)p, wherein R is polyvalent hydrocarbon radicals or multivalence halogenated hydrocarbon group, and subscript p is to indicate in per molecule The integer of isocyanate groups quantity.Subscript p is greater than or equal to 1.Alternatively, subscript p is 2,3 or 4;Alternatively, subscript p is 2 or 3; And alternatively, subscript p is 2.When subscript p is 2, R is divalent hydrocarbyl mission.When subscript p is 3, R is trivalent hydrocarbon radical group.Instantly When mark p is 4, R is tetravalence hydrocarbyl group.
The example of isocyanate compound is monomeric diisocyanate and polymeric isocyanate.Monomeric diisocyanate includes aromatics Diisocyanate, such as between tetramethylxylene diisocyanate (TMXDI), toluene di-isocyanate(TDI) (TDI), phenylene two it is different Cyanate, xylene diisocyanate, 1,5- naphthalene diisocyanate, chlorine phenylene 2,4- diisocyanate, two isocyanide of dimethylbenzene Acid esters, dianisidine diisocyanate, toluidine diisocyanate and alkylated benzene diisocyanates;Aliphatic and alicyclic isocyanide Acid esters, such as hexamethylene diisocyanate (HDI), hydrogenated methylene diphenyl diisocyanate (HMDI), 1- isocyanate group- 3- isocyanatometyl -3,5,5- trimethyl-cyclohexane (isophorone diisocyanate, IPDI) and nonyl triisocyanate (TTI), the aromatic diisocyanates that methylene interrupts, such as methylene-diphenyl-diisocyanate, especially 4,4'- isomery Body (MDI), including alkylated analogs, such as 3,3'- dimethyl -4,4'- diphenyl-methane diisocyanate;Hydrogenation material, Such as cyclohexylene diisocyanate, 4,4'- methylene biscyclohexyl diisocyanate;Aralkyl diisocyanates are mixed, it is all Such as tetramethyl xylene phenyl diisocyanate, 1,4- bis- (1- isocyanate group -1,1'- dimethyl methyl) benzene, OCNC (CH3)2C6H4C(CH3)2NCO and polymethylene isocyanates, such as Isosorbide-5-Nitrae-tetramethylene diisocyanate, 1,5- pentamethylene two Isocyanates, 1,6- hexamethylene diisocyanate (HDI), 1,7- heptamethylene diisocyanate, 2,2,4- and 2,4,4- tri- Methyl hexamethylene diisocyanate, 1,10- decamethylene diisocyanate and 2- methyl-1,5- pentamethylene diisocyanate Ester, vinyl isocyanate;And their combination.
Polymeric isocyanate include isocyanate dimerization, urea diketone or urea diacetyl and carbodiimide, isocyanuric acid ester, Isocyanuric acid ester, imidoyl-oxadiazine-diketone, uretonimine and linear polymer α-nylon;And derivative isocyanates, By making Bifunctionalized or multiple functionalized isocyanates react to form allophanate or biuret chemical combination with various compounds Object or isocyanate-functional carbamate or other prepolymers.Some polyisocyanates are Bifunctionalized, i.e. per molecules With 2 isocyanate groups.Some isocyanate groups having more than two.Another example is polymeric diphenylmethane two is different Cyanate is there are two tools, the mixture of the molecule of three and four or more isocyanate groups, average functionality Two, usually 2.7 can be greater than.Isocyanate functional compound of the isocyanate functionality greater than two may act as crosslink sites.City (Rhodia in the New Jersey city Crane Bai Li is public with Tolonate XIDT 70SB for the isocyanate-functional organic compound sold Take charge of a kind of isophorone diisocyanate tripolymer (70% solid, the 12.3 weight % of (Rhodia, Cranbury, NJ) sale NCO it)) is illustrated with Desmodur N-100 polyisocyanates (deriving from Mobay company).
Alternatively, a) isocyanate compound may include blocked isocyanate.Isocyanate groups can be by common sealing end Agent (such as, phenol, nonyl phenol, diacetylmonoxime, caprolactam etc.) sealing end.These blocked isocyanates can pass through any routine side Method release, is such as heated at temperatures greater than room temperature to react with chain extender and polysiloxane, to construct polyurethane- Poly organo alkyl copolymer.
Initial substance b1) methanol-functional organo-siloxanes
In the above-mentioned methods, b1) unit of the methanol-functional organo-siloxanes comprising following formula:
In this is modular, each RM、RD, subscript b, subscript c, subscript w1, subscript w3, subscript d, subscript e and subscript h institute as above It states.Methanol-functional organo-siloxanes example in WO2008/088491, United States Patent (USP) 6,528,121 and United States Patent (USP) 7, It is disclosed in 452,956.Methanol groups can be located at end or side chain.Alternatively, methanol groups can be located at end.
Alternatively, b1) methanol-functional organo-siloxanes may include lower formula (II) α, ω-Bifunctionalized poly- two is organic Siloxanes: RCRM 2Si-RDX-(RM 2SiO)r-(RM 2)SiRDX-SiRM 2RC, wherein each RCIt independently is formula HO-RD-(ORD)b? Methanol functional group, wherein subscript b, RMAnd RDAs described above, each RDXIndependently selected from O or as above according to RDThe divalent hydrocarbon Group, and subscript r indicates methanol-functional organo-siloxanes degree of polymerization of formula (II).Subscript r > 0.Alternatively, subscript r It can be 1 to 1,000,000 or 50 to 1,000, and 200 to 700.Alternatively, subscript r is 0 to 200,000 or 0 To 200,000 or 0 to 100,000 or 0 to 50,000 or 0 to 10,000 or 0 to 5,000 or 0 to 1, 000 or 1 to 1,000 perhaps 1 to 500 perhaps 1 to 200 and 5 to 150.Alternatively, each RDXFor O.
Initial substance b2) amine-functional polysiloxane
Amine-functionalized polysiloxane includes the unit of following formula:
Wherein RMAnd RDAnd subscript b, d, e, h and i are as described above.Amine groups can be located at end or side chain.Alternatively, amine groups End can be located at.
The polysiloxane of exemplary amines sealing end includes the terminal units of following formula:
Wherein Me indicates methyl group, and Bu indicates butyl group;And also comprising containing (RM 2SiO2/2)d(RMSiO3/2)e (SiO4/2)hOne of or a variety of units, wherein RM、RDAnd subscript i, d, e and h are as described above.
Initial substance c) chain extender
Chain extender can be formula HO-RDThe dihydric alcohol of-OH, wherein RDAs defined above.Suitable dihydric alcohol includes 1,3- fourth Glycol;1,4- butanediol;1,6-HD, 1,10- decanediol;1,6- hexamethylene glycol;2,2- dimethyl -1,3- the third two Alcohol;1,4 cyclohexane dimethanol;- two -2- ethyl alcohol of 1,1'- isopropylidene-bis--(p-phenylene-oxygroup);Poly- (tetramethylene Ether) glycol;And ethylene glycol.Alternatively, chain extender can be the diamines containing 2 to 20 carbon atoms, such as 1,2- diamino second Alkane;1,4- diaminobutane;1,2- propane diamine;Hexamethylene diamine;Diethylenediamine;5- amino -1- (amino methyl) -1, 3,3- trimethyl-cyclohexane;4,4' methylene bis (cyclohexylamine);And ethanol amine.Alternatively, chain extender can be two mercaptan, two Carboxylic acid or dicyclic oxide.Suitable chain extender discloses in such as United States Patent (USP) 4,840,796 and 5,756,572.
Initial substance d) solvent
Solvent can be added during this method to prepare copolymer described herein.It will dissolution copolymer and relatively not Any organic compound reacted with isocyanates and amine and/or carbinol compound is suitable as solvent.Example include aliphatic hydrocarbon, Aromatic hydrocarbon, ester, ether, ketone and amide.Exemplary solvent includes methyl ethyl ketone, ethyl acetate, butyl acetate or tetrahydrofuran.
The amount of solvent for use depends on the performance (certain party including the preparation of structure, molecular weight and copolymer of copolymer Method), and can be 0 to 99%.Generally for the copolymer of higher molecular weight, especially when without using high torque mixing machinery When, solvent can be added to reduce viscosity and system is made to be easier to handle during the progress for the method for preparing copolymer.If point Son amount is relatively low and/or uses high torque mixing apparatus such as double screw extruder, then does not need using solvent.When use solvent When, based on the combination weight of all initial substances used, amount can for 0% to 99% perhaps 0% to 80% or 1% to 60%, and 5% to 50%.
According to desired poly organo alkyl structure and molecular weight, initial substance a), b), c) and d) and/or e) (when depositing When) amount can be widely varied, to obtain copolymer described in the formula of this paper.The isocyanate groups of initial substance a) be directed to The molar ratio of the reactive hydrogen of methanol or amine groups on the selected polysiloxanes of initial substance b) can be 0.1 to 100, or 0.1 to 50 perhaps 0.1 to 10 perhaps 0.1 to 2 perhaps 0.1 to 1.5 perhaps 0.1 to 1.25 perhaps 0.1 to 1.1 or 0.1 to 1.05 perhaps 0.1 to 1.01 perhaps 0.1 to 1 perhaps 0.1 to 0.9 perhaps 0.1 to 0.5 perhaps 0.5 to 50 or 0.5 to 10 perhaps 0.5 to 2 perhaps 0.5 to 1.5 perhaps 0.5 to 1.25 perhaps 0.5 to 1.1 perhaps 0.5 to 1.05 or 0.5 to 1.01 perhaps 0.5 to 1 perhaps 0.5 to 0.9 and 0.4 to 0.7.
Between the reactive hydrogen on the hydroxyl or amine groups or other reactive groups on isocyanate groups and chain extender Molar ratio can be 1.001 to 1,000,000 or 1.001 to 500,000 or 1.001 to 200,000 or 1.001 To 100,000 or 1.001 to 50,000 or 1.001 to 10,000 or 1.001 to 5,000 or 1.001 to 1, 000 perhaps 1.001 to 500 perhaps 1.001 to 100 perhaps 1.001 to 50 perhaps 1.001 to 20 or 1.001 to 10, Perhaps 1.001 to 5 perhaps 1.001 to 4 perhaps 1.001 to 3 perhaps 1.001 to 2 perhaps 1.001 to 1.5 or 1.001 To 1.3 perhaps 1.001 to 1.2 perhaps 1.01 to 20 perhaps 1.01 to 10 perhaps 1.01 to 5 perhaps 1.01 to 4 or 1.01 to 3 perhaps 1.01 to 2 perhaps 1.01 to 1.5 perhaps 1.01 to 1.3 and 1.01 to 1.2.
Initial substance e) catalyst
It can be catalyzed by initial substance e) catalyst comprising above-mentioned initial substance reaction a), b) and c).Suitably Catalyst includes tertiary amine and metal salt, such as the salt of tin.The tin compound that can be used as the catalyst of this paper includes the oxygen of wherein tin Change state is those of+4 or+2 compounds, i.e. tin (IV) compound or tin (II) compound.The example of tin (IV) compound includes Stannic salt, such as dibutyl tin dilaurate, dilaurate, two (normal-butyl) diketone tin, dibutyltin diacetate, Dibutyitin maleate, dibutyl tin diacetyl acetonate, dimethoxy dibutyl tin, three suberic acid methoxycarbonyl phenyltins, two Sad dibutyl tin, dioctyl phthalate dibutyl tin, three cerinic acid isobutyl group tin, two butyric acid stannous methides, two neodecanoic acid stannous methides, two Neodecanoic acid dibutyl tin, tartaric acid tin triethyl, dibenzoic acid dibutyl tin, three -2 ethyl hexanoic acid butyl tins, oxalic acid two are pungent Ji Xi, tin octoate, oleic acid tin, butyric acid tin, aphthenic acids tin, dimethyltin chloride, their combination and/or their part water Solve product.Tin (IV) compound is known in the art and is commercially available, the A Xima particularization such as from European Switzerland Xue Pin company (Acima Specialty Chemicals, Switzerland, Europe)740 Hes 4202, the said firm is the business department of Dow Chemical (Dow Chemical Company).The example of tin (II) compound Tin (II) salt including organic carboxyl acid, such as oxalic acid tin (II), two tin octoates (II), diethyl caproic acid tin (II), two laurels Sour tin (II)), the tin salt of carboxylic acid, such as stannous octoate (stannous octoate), stannous oleate, stannous acetate, laurel Sour stannous, stearic acid stannous, naphthoic acid stannous, caproic acid stannous, succinic acid stannous, stannous octoate (stannous caprylate) with And their combination.Other metal salts are also the suitable catalyst of the reaction.Example includes zinc salt, such as zinc acetate and cycloalkanes Sour zinc.Lead, bismuth, cobalt, iron, antimony or sodium salt such as lead octoate, bismuth nitrate and sodium acetate can also be catalyzed the reaction.In certain feelings Under condition, organomercurial compound also can be used.Optionally co-catalyst can also be used together with above-mentioned catalyst.Alternatively, can be with Using the combination of two or more catalyst, such as to provide reaction more achievable than single catalyst reaction faster, or Balance reaction initiation time and deadline more preferably.
Initial substance f) organic polyhydric alcohol
Organic polyhydric alcohol is optionally combined with b) polysiloxane, to prepare above-mentioned copolymer (A) and/or copolymer (B).Suitable organic polyhydric alcohol is the organic polymer containing two or more hydroxyl groups.For having for initial substance f) It is more that machine polyalcohol can be polyether polyol, polyester polyol, polyacrylate polyol, polycaprolactone polyol, polyurethane Two kinds in first alcohol, polycarbonate polyol, polybutadiene diol, other polymers polyalcohol or these organic polyhydric alcohols or It is more kinds of.Also the copolymer polyols of the polyalcohol of two or more seed types can be used.Also it can be used in polymer knot On structure there are other to modify such as fluorinated polymerized polyalcohol.Alternatively, suitable organic polyhydric alcohol can be organic diol.Properly Organic diol include polyoxyalkylene glycol, such as polyoxyethylene glycol, oxide glycols and polyoxygenated Butylen glycol;Or polycarbonate glycol.Other organic diols include glycerol.It is prepared to adjust that organic polyhydric alcohol can be added The surface energy and/or hydrophily/mechanical performance of copolymer.Combination weight based on all initial substances for being used to prepare copolymer Amount, additive amount can be 0% to 95% perhaps 0% to 75% perhaps 0% to 50% and 1% to 25%.
Initial substance g) optional end-capping reagent (enblocker)
Above-mentioned copolymer (A) and/or (B) optionally with blocking agent reaction, by any remaining isocyanate groups, Hydroxyl group or amine groups are converted into another type of reaction or non-reactive group.Suitable end-capping reagent includes but is not limited to alcohol (such as ethyl alcohol, propyl alcohol, butanol), carboxylic acid (such as acetic acid) and the alcohol and carboxylic acid containing aliphatic degree of unsaturation.Mercaptan, azanol, Glycol, amino acid and amino sugar also are suitable as end-capping reagent.
The method for preparing copolymer (B)
The same procedure for being used to prepare copolymer (A) can also be used for preparing copolymer (B), the difference is that, it will change The ratio of initial substance is to obtain desired copolymer (B) composition.It would be recognized by those skilled in the art that the copolymer of selection (A) and copolymer (B) is different from each other.Copolymer (A) and copolymer (B) are at least one performance (such as structure, copolymer unit Selection, copolymer unit sequence and molecular weight) on be different from each other.
Prepare the method condition of copolymer
The above method can be carried out in the case where being heated or not heated.Reaction temperature depends on initial substance a), b) and c) Selection and with the presence or absence of any one of d), e), f) and/or g), however at 1 atmosphere pressure temperature range can- 20 DEG C to 150 DEG C;Perhaps 0 DEG C to 100 DEG C and 20 DEG C to 60 DEG C in the range of.Carry out this method pressure be not to It closes important.
The above method can in any convenient equipment in batches, semi-batch, semicontinuous or continuous mode carry out.Work as preparation When the copolymer of higher molecular weight (for example, when using higher molecular weight initial substance when), this method can extruder such as It is carried out in double screw extruder.Device and method described in United States Patent (USP) 5,756,572 can be used to prepare for above-mentioned copolymer, The difference is that using above-mentioned initial substance.
Skin contact adhesive
Skin contact adhesive can be prepared by including the method for above-mentioned hardening copolymer compositions.Hardening can lead to It crosses any convenient mode to carry out, composition is such as cooled to 15 DEG C to 40 DEG C of room temperature, and/or moved from composition Except solvent.The skin contact adhesive prepared by hardening copolymer compositions can be used for using such as medical adhesive tape Adhesive, the adhesive for prosthese, ostomy appliance adhesive, is used for medical monitor at the adhesive for wound dressing The adhesive of tool, adhesive, the adhesive for the treatment of scar therapy and transdermal drug delivery system for cosmetics drug paste System.
Above-mentioned skin contact adhesive composition and skin contact adhesive include (I) above-mentioned copolymer compositions.Skin Contact adhesive composition also may include (II) excipient.Above-mentioned skin contact adhesive composition and skin contact adhesive can It optionally also include (III) active constituent.
(II) excipient
Excipient can be any ingredient different from ingredient (I) and (III), and excipient is added in composition, To provide one or more benefits during and/or after preparing composition, and/or for skin contact adhesive provide one Kind or a variety of benefits.For example, excipient can be (II-1) stabilizer, (II-2) binder, (II-3) filler, (II-4) solubilising Agent, (II-5) skin penetration enhancer, (II-6) adhesion promoter, (II-7) improve penetrability reagent or (II-1), (II- 2), the combination of two or more in (II-3), (II-4), (II-5), (II-6) and (II-7).
(II-1) stabilizer
Composition is also optionally including (II-1) stabilizer.Stabilizer can include: antioxidant, such as vitamin A, dimension Raw element E, vitamin C, retinyl palmitate, selenium, benzenpropanoic acid, bis- (1,1 the dimethyl-ethyI) -4- hydroxyls (hycroxy)-of 3,5- C7-C9 branched alkyl ester (derived from BASF (BASF)1135), [3- (the 3,5- di-t-butyl-of pentaerythrite four 4- hydroxy phenyl) propionic ester] (derived from BASF (BASF)1010), octadecyl -3- (the tertiary fourth of 3,5- bis- Base -4- hydroxy phenyl) propionic ester (derived from BASF (BASF)1076), 1,3,5- trimethyl -2,4,6- three (3,5- di-tert-butyl-4-hydroxyl benzyl) benzene (equally derived from BASF (BASF)1330), 2- methyl -4,6- Bis- [(pungent sulfenyl) methyl] phenol (derive from BASF (BASF)1520), 2,6- di-t-butyl methylphenol (BHT), 2,2'- methylene-it is bis--(6- tert-butyl-4-methyl-Phenol) (derive from it is bright contain (LanXess) Vulkanox BKF) or Their mixture.Alternatively, stabilizer may include amino acid, such as cysteine, methionine or their combination.Alternatively, Stabilizer may include p-hydroxybenzoate, such as methyl p-hydroxybenzoate, propylparaben or their combination. The amount of stabilizer depends on various factors, and whether these factors include whether by heating combination and by adding ingredient (III), However, the weight based on composition, stabilizer can with 0% to 2% or 0% to 1% or 0.1% to 1% or 0.2% to 0.7% and 0.2% to 0.6% amount exist.
(II-2) binder
Optionally ingredient (II-2) binder is added in composition.Suitable binder includes carbohydrate and its derivative Object is (for example, disaccharides such as sucrose and lactose, polysaccharide such as starch or cellulose or sugar alcohol such as xylitol, D-sorbite or wheat Bud sugar alcohol.Other suitable binders include protein, such as gelatin.The amount of binder depends on various factors, including laminated The type of product and selection to other compositions in composition, however, the weight based on composition, the amount of binder can be 0% to 50%.
(II-3) filler
Optionally ingredient (II-3) filler is added in composition.Suitable filler for ingredient (II-3) Including but not limited to silica, to help to prevent the cold flow of composition from leaving supporter.The type of selected filler Make the adhesion strength that can not adversely influence skin contact adhesive with amount.Weight based on composition, the amount of filler It can be 0% to 2% or 0% to 1%.
(II-4) solubilizer
Optionally ingredient (II-4) solubilizer is added in composition.Suitable solubilizer include dimethyl sulfoxide, Povidone (PVP) and natural oil such as mineral oil, sunflower oil and peanut oil.Ester, glycol, polyethers can help to dissolve (III) active constituent is (that is, make ingredient (III) keep noncrystalline in composition and skin contact adhesive prepared therefrom State, to promote active constituent to penetrate to the skin (and/or into skin)).Weight based on composition, solubilizer can Perhaps 0% to 40% perhaps 0% to 25% to be perhaps up to 20% and 20% greater than 0% with 0% to 50% Amount to 25% exists.Alternatively, the solubilizer suitable for ingredient (II-4) can be the above-mentioned solvent for being used to prepare copolymer.
(II-5) skin penetration enhancer
Optionally ingredient (II-5) skin penetration enhancer is added in composition.Suitable skin penetration enhancer Including glycols, such as propylene glycol and polyethylene glycol;Organic acid, such as oleic acid;Fatty alcohol, such as oleyl alcohol;And amine.Ingredient (II- 5) amount depends on various factors, these factors include that will be applied to which aspect by the skin contact adhesive of composition preparation, Skin contact adhesive is by the time span of application and purpose (for example, wound dressing or transdermal drug delivery), however, base In the weight of composition, which can be in the range of 0% to less than 20% or 1% to 2%.
(II-6) adhesion promoter
Substance known in the art as skin contact adhesive can be mixed with composition as described herein, with adjustment Binder performance, the amount of peeling force needed for such as removing skin contact adhesive and remaining residue on the skin.? These substances can be used as adhesion promoter herein.Exemplary adhesion promoter includes aqueous colloidal.The amount of adhesion promoter Depending on the type of selected adhesion promoter and the amount of desired adhesion strength, however, the weight based on composition, adherency promotees Amount into agent can be 0% to less than 20% or 1% to 2%.
(II-7) improve the reagent of penetrability
Ingredient (II-7) is the reagent for improving penetrability, and optionally the reagent is added in composition.For ingredient (II-7) suitable reagent includes but is not limited to aqueous colloidal, gelatin, polymer such as CMC carboxymethyl cellulose and polyoxygenated Ethylene.The amount of ingredient (II-7) depends on various factors, these factors include selection to other compositions in composition and by The final use of its skin contact adhesive prepared.However, the weight based on composition, the amount of ingredient (II-7) can be 0.1% to 50% or 0.1% to 25% perhaps 0.1% to 10% or 1% to 10%.Those skilled in the art will recognize Know, certain reagents for improving penetrability can function as mucoadhesive, which makes to apply when water capacity increases Material can be adhered to preferably.
When selecting the ingredient of above-mentioned composition, overlapping may be present between component type, this is because as described herein Certain ingredients can have more than a kind of function.For example, certain aqueous colloidals can be used as improve penetrability reagent (II-7) and It can be used as adhesion promoter (II-6).Gelatin can be used as improving the reagent (II-7) of penetrability and can be used as binder (II- 2).Certain nutriments such as vitamin A and vitamin E can be used as stabilizer (II-1) and active constituent (III).By ingredient When being added in composition, these ingredients are different from each other.
(III) active constituent
The composition also optionally includes (III) active constituent.For example, being used for treating acne when composition will be used to prepare It is connect using the application of, cosmetics drug paste, transdermal drug delivery application and/or by the skin in the application of active delivery to skin It, can be with adding ingredient (III) when touching adhesive.Given activity ingredient used is immaterial to the invention, and such as this paper institute It is interpreted to be intended in the broadest sense to generate organism applied by it with, term " active constituent " some beneficial The substance of effect.
Example active ingredient suitable for ingredient (III) includes but is not limited to: act on central nervous system drug, It influences the drug of renal function, influence the drug of cardiovascular function, the drug of gastrointestinal function is influenced, for treating the medicine of vermination Object, antimicrobial such as silver, silver compound and/or Chlorhexidine, nutriment, hormone, steroids, and for treating skin The drug of disease;See, e.g., disclosed in 2007/0172518 [0014] section of patent application publication US those and Those of listed in PCT Publication WO2007/092350 page 21 to 28.
Other suitable active constituents for ingredient (III) include non-steroidal anti-inflammatory drugs, such as salicylate, such as second Acyl salicylic acid;Propanoic derivatives, such as (RS) -2- (4- (2- methyl-propyl) phenyl) propionic acid (brufen);Acetogenin, example Such as 2- { 1- [(4- chlorphenyl) carbonyl] -5- methoxyl group -2- Methyl-1H-indole -3- base } acetic acid (Indomethacin), bmap acid spreads out Biology;Anthranilic acid derivative, cox 2 inhibitor, for example, N- (4- hydroxy phenyl) acetamide N- (4- hydroxy phenyl) second Amide (paracetamol) and sulfonanilide.Other suitable active constituents for ingredient (III) include local anaesthesia Agent, such as containing those of ester group local anesthetic, for example, 4-aminobenzoic acid ethyl ester (benzocainum);Contain amide groups Those of group local anesthetic, for example, 2- (lignocaine)-N- (2,6- 3,5-dimethylphenyl) acetamide (lidocaine);And Natural local anesthetic, such as (1R, 2S, 5R) -2- isopropyl -5- methyl cyclohexanol (menthol).
It would be recognized by those skilled in the art that in the laminate being described below, it can be by as described herein group It closes in object and is connect comprising ingredient (III) (that is, before hardening the composition to form skin contact adhesive) to prepare skin Adhesive is touched, wherein to include (III) active constituent.Alternatively, can include in laminate by (III) active constituent In independent stock, and it is not mixed into the skin contact adhesive prepared by skin contact adhesive composition.
The amount of (III) active constituent used in skin contact adhesive composition depend on various factors, these because Element includes type of the selection for the active constituent of ingredient (III), and will wherein mix the class of the laminate of active constituent Type, and the selection to any other ingredient in composition.However, the weight based on skin contact adhesive composition, at The amount of point (III) can be 0% to 45%, be perhaps greater than 0% to 25% be perhaps greater than 0% to 15% or be greater than 0% to 10%, perhaps it is greater than 0.1% to 10% or greater than 1% to 10%.
Laminate
Laminate includes:
I) supporter, which has surface towards skin and opposite surface, and (it means the table away from skin Face),
Ii) skin contact adhesive, the skin contact adhesive in at least part on the surface towards skin, wherein Skin contact adhesive has the skin contact surface opposite with the surface towards skin of supporter.
Supporter is the material that can be readily applied to a part of wearer's body.Supporter can be plastic foil, all Such as polyurethane, polyolefin such as low density polyethylene (LDPE) (LDPE), medium density polyethylene (MDPE), high density polyethylene (HDPE) (HDPE), Or polypropylene;Polyolefin/polyurethane compound;Polyester;Or ethane-acetic acid ethyenyl ester (EVA).Alternatively, supporter can be paper, knit Object (woven or nonwoven), silicon rubber or foam.All or part of of supporter optionally has multiple holes (for example, beating Hole or aperture), to provide gas permeability in laminate.Suitably supporter is known, see, e.g. PCT Publication WO2013/030580 and WO2014/116281 page 5 to 6.
Skin contact adhesive is located in at least part on the surface towards skin of supporter.For certain applications, Such as transdermal drug delivery, skin contact adhesive can cover all or most of surface towards skin of supporter, with Maximize the surface area that drug can be shifted by it.Alternatively, for example, when skin contact adhesive will be used to adhere to absorbing material When to wound, in a part on the surface towards skin that skin contact adhesive can be located at supporter.Skin on supporter The amount (thickness) of contact adhesive will depend on various factors and change, these factors include application (for example, fistulization, wound Nursing and other application may have thicker skin to connect on a support in the application for the strong adhesion strength for needing the long period Adhesive is touched, but the adhesive for transdermal drug delivery or bandage or medical adhesive tape there can be relatively thin skin on a support Skin contact adhesive.Thickness can be uniformly.Alternatively, on any given supporter thickness can be it is non-uniform, for example, It is thicker towards the middle and relatively thin at the edge of supporter or adjacent edges).However, the thickness of skin contact adhesive can In the range of 0.0635mm to 2.54mm or 0.254mm to 1mm.
Fig. 1 is the partial cross-section of laminate 100 according to the present invention.Laminate 100 includes supporter 101, should Supporter has the layer of the skin contact adhesive 102 on the surface 104 towards skin of supporter 101.Release liner 103 Cover the surface 105 of the contact skin of the layer of skin contact adhesive 102.Supporter 101 can be for for medical adhesive tape or bonding The backing of agent bandage or other wound dressings, and as described above.
The layer of skin contact adhesive can be continuous or discontinuous.When discontinuous, which can be various forms, Such as line, line segment, point or spotwise.Discontinuous form can be in uniform pattern in supporter whole surface, or prop up Supportting has different pattern at the different zones of object.Fig. 4 shows an example, and the figure shows (do not show for ostomy appliance Flange 400 in out).Flange 400 has the supporting member 401 for limiting hole 403.Skin contact adhesive 402 as described herein In the discontinuity layer (being shown as toroid) being formed on supporting member 401.
Laminate also may include one or more layers other layer.For example, laminate may also include iii) release liner, The skin contact surface of release liner covering skin contact adhesive.Release liner is removable, and can used It is used during laminate transports and stores before laminate.Bonding can be contacted come exposed skin by removing release liner Agent.
Suitable release liner includes by polyethylene, polypropylene, fluorocarbon and coated with the peeling paper of fluorosilicone The liner for being made or coating with the plastic foil for being coated with fluorosilicone.Suitable release liner is known, and in such as PCT It is described in open WO2007/092350.It is not wishing to be bound by theory, it is believed that prepared by hardening composition as described herein A benefit of skin contact adhesive be free from fluoride coating (for example, without fluorocarbon and not flucride siloxane) Release liner can be effectively used together with skin contact adhesive.Release liner with fluoride coating is usually than without fluorination The release liner of coating is more expensive.Alternatively, release liner includes the liner for being made or being coated by polyethylene or polypropylene.
Laminate optionally also includes iv) absorbed layer.When absorbed layer will directly contact skin (for example, wound), Such as when laminate is that can will inhale as in Fig. 2 or when Canadian Patent discloses adhesive bandage shown in CA02585933 Receive the skin contact surface that layer is installed to skin contact adhesive.Fig. 2A is shown comprising skin contact adhesive as described herein The perspective view of the adhesive bandage 200 of 202 thin layer.Fig. 2 B shows the adhesive bandage 200 of the interception of the line A-A in Fig. 2A Cross-sectional view.Adhesive bandage 200 has the plastic support 204 of punching, and wherein the layer of skin contact adhesive 202 is located at On the surface 203 towards skin of supporter 204.Absorbed layer 201 is located at the skin contact surface of skin contact adhesive 202 On 205.Alternatively, for example, when skin contact adhesive as described herein is used for such as shown in PCT Publication WO2007/092350 Wound dressing in when, absorbed layer can be between skin contact adhesive and supporter.
Absorbed layer can be any suitable material, can such as absorb the textile fabric or polymer composition (example of fluid Such as, from the secretion of wound).Absorbed layer can be commercial product, and the example of absorbing polymeric is referring to PCT Publication WO2007/ Page 092350,12 to 15.Example includes but is not limited to: thermoplastic polymer, gathers block copolymer (in addition to ingredient (A)) Alkene, hydrogel and aqueous colloidal.
Laminate also may include v) carrier.Carrier can be used for providing certain rigidity for laminate, and make laminated Product can be placed on wound in the case where wrinkling minimizes, and avoid laminate being applied to wearer's phase Between skin contact adhesive itself adhere to.Such as it after laminate is fixed to skin with bonding mode, optionally moves Except carrier.Carrier is mountable on the opposite surface (it means away from the surface of skin) of supporter.
Carrier can be ethylene vinyl acetate (EVA), polyethylene film, polyester film or the paper coated with EVA coating.This field It will be recognized that carrier can have and supporter same structure material or different configuration material.As used herein, it carries Body refers to independent and discrete laminate component.
Fig. 3 is the partial cross-section of substitution laminate 300 according to the present invention.Laminate 300 has supporter 304, the supporter is with the surface 305 towards skin and is intended to away from the opposite surface 303 of skin.Skin contact is bonded Agent (described herein) 308 is installed to the surface 305 towards skin of supporter 304.Skin contact adhesive 308, which is formed, has skin The layer of skin contact surface 309.Release liner 310 (there are two parts that can individually remove) covering skin contact adhesive 308 skin contact surface 309.Laminate be also included in supporter 304 surface 305 towards skin and skin contact it is viscous Absorbed layer 306 between the opposite surface 307 of mixture 308.Laminate also includes carrier 30 as one kind 2, which has towards skin The surface of skin and opposite surface 301.Carrier 30 as one kind 2 is removably attached to the opposite surface 303 of supporter 304.
The method for being used to prepare laminate
The method for being used to prepare laminate includes:
I the layer of composition described above) is formed in at least part on the surface towards skin of supporter, and
II) hardening composition is to form skin contact adhesive.
This method is optionally further include: III) release liner is applied to it is skin contact adhesive with supporter face The skin contact surface opposite to the surface of skin.Step III) can be in step II) before or after carry out.This method can also wrap Include: IV) before hardening in step II), the compressed compositions between supporter and release liner.
It can be by being commonly used in applying a composition to any convenient mode that contact adhesive is applied to substrate Supporter.Composition can apply for example, by fusion coating, scraper doctor blade technique, solvent cast, blade coating or roller coating.First It can apply a composition on supporter or release liner.Such as method described in United States Patent (USP) 5,756,572 can be used Apply a composition to supporter (being taken with composition as described herein for contact adhesive described in bibliography).Alternatively, Composition can be sandwiched between supporter and release liner, and can apply heat and/or pressure to form laminate, and And/or person's cross-linked composition is to form skin contact adhesive.Laminate can be prepared as described in WO2015/075448, no It is with place, replaces polyurethane gle adhesive formulation disclosed in bibliography using composition of the invention.
Prepare the method for laminate optionally further include: III) it sterilizes to laminate.Include skin contact The laminate of adhesive can be sterilized.Known sterilization method can be used, and (such as, irradiation is (for example, with electron beam or γ spoke Penetrate) and/or (such as, with xeothermic or steam) is heated to sterilize to laminate.As described above, step III) in go out Bacterium can be in step I) or step II) carried out later as independent step.Alternatively, sterilizing can be with step I) and/or step II) It carries out simultaneously.For example, can be heated and/or be irradiated with cross-linked composition, solvent and/or sterilizing are removed.
Using
Skin contact adhesive as described herein is suitable for various applications.The skin contact prepared by cross-linked composition Adhesive can be used for using such as the adhesive of medical adhesive tape, the adhesive for wound dressing, the bonding for prosthese Agent, ostomy appliance adhesive, for the adhesive of medical monitor tool, for the adhesive and transdermal of scar therapy treatment Drug delivery system.
For example, above-mentioned laminate may include supporter and above-mentioned on all or part of surface of supporter Skin contact adhesive.Skin contact adhesive is formed as continuous or discontinuous layer.In one embodiment, above-mentioned layer Combination product can be used as adhesive element.Skin contact adhesive can be applied to the surface towards skin of supporter, and Skin contact adhesive can be used that supporter is adhered to the skin of wearer.For example, above-mentioned skin contact adhesive can be used for Prosthese, which is adhered to wearer with limbs difference or skin contact adhesive, can be used for adhering to ostomy appliance into tool Foraminate patient.Ostomy appliance generally includes the pouch for collecting waste, is attached to the flange for limiting hole.Flange exists There is adhesive, wherein adhesive adheres to the skin of patient with small holes around opening on surface towards skin (as described in figure 4 above).
Skin contact adhesive as described herein can be used in wound care and fistulization nursing application to adhere to skin, It can replace contact adhesive disclosed in patent application publication US 2005/0163978, or replace U.S. Patent application public Open adhesive used in US2014/0323941.
Skin contact adhesive as described herein is suitable for wound dressing.For example, skin contact bonding as described herein Agent can replace the aqueous colloidal in United States Patent (USP) 5,998,694 to be used as the barrier layer for contacting skin.Skin contact as described herein Adhesive can be used for PCT Publication WO2007/092350 and patent application publication US 2009/0105670 and US2015/ In 0313593 wound covering object.
Alternatively, skin contact adhesive as described herein can be used for transdermal drug delivery systems.In this embodiment, on Stating composition includes ingredient (III) active constituent, and also may include (II) excipient.It is not wishing to be bound by theory, it is believed that this Invention can provide following benefit: cross-linked composition can not adversely influence (III) active constituent to form skin contact adhesive. Skin contact adhesive of the invention can be used for such as United States Patent (USP) 4,840,796 and 4,951,657 and U.S. Patent application In transdermal drug delivery systems described in open US2005/0048104 and US2007/0172518.
Coating composition
Above-mentioned copolymer compositions can or be used in coating composition, and the coating composition is for example in substrate Form coating.Coating composition includes: (a) above-mentioned copolymer compositions;And (b) coating additive.Coating additive is optional From (b1) water scavenger, (b2) pigment, (b3) diluent, (b4) filler, (b5) antirust agent, (b6) plasticizer, (b7) thickening Agent, (b8) pigment dispersing agent, (b9) flow aid, (b10) solvent, (b11) adhesion promoter, (b12) catalyst, (b13) Having machine aided binder, (b14) siloxanes to help, binder, (b15) delustering agent, (b16) levelling agent, (b17) wax, (b18) is quenched adds Add agent, (b19) anti-scratch additive, (b20) gloss modified additive, (b21) stabilizer and (b22) crosslinking agent, or (b1), (b2)、(b3)、(b4)、(b5)、(b6)、(b7)、(b8)、(b9)、(b10)、(b11)、(b12)(b13)、(b14)、(b15)、 (b16), combination two or more in (b17), (b18), (b19), (b20), (b21) and (b22).Suitable filler packet Include silica and titanium dioxide or zirconium dioxide.Suitable adhesion promoter includes alkoxy silane, such as 3- glycidol Oxygroup propyl trimethoxy silicane.Suitable solvent as prepared described in the method for copolymer above.Suitably (b2) pigment, (b3) diluent, (b4) filler, (b5) antirust agent, (b6) plasticizer, (b7) thickener, (b8) pigment dispersing agent, (b9) stream The example of dynamic property auxiliary agent, (b10) solvent and (b11) adhesion promoter is disclosed in U.S. Patent Application Publication No. 2015/0031797 In PCT Publication WO2015/097064, WO2015/100258 and WO2016/126362.Based on being used to prepare coating composition All initial substances combination weight, in the coating composition as initial substance (b12) catalyst can with it is described above Initial substance e) it is identical, and can be present in coating composition with the amount of 0.01 weight % to 5.00 weight %.Starting material Matter (b13) is to have machine aided binder, such as polyalcohol, polyamine or polyisocyanates;Based on the institute for being used to prepare coating composition There is the combination weight of initial substance, which can be added in coating composition with 0% to 99% amount.Initial substance (b14) binder is helped for siloxanes, based on the combination weight of initial substances all in coating composition, which helps binder It can be added with 0% to 99% amount.Initial substance (b15) is delustering agent, the group based on initial substances all in coating composition Weight is closed, which can be 0% to 30%.Initial substance (b16) is levelling agent, and the levelling agent is with the 0% of coating composition To 10% presence.Initial substance (b17) is wax, which can account for the 0% to 20% of coating composition described herein.Initial substance (b18) it is flocking additive, can be added in coating composition with 0% to 20% amount.Based on all in coating composition The total weight of initial substance, initial substance (b19), (b20), (b21) and (b22) combination can be 0% to 15%.
Hardenable coating composition is to be formed on the substrate coating, such as priming paint or Topcoating.Substrate can be metal, glass Glass, timber, the coat of paint, plastic foil, fiber and/or textile fabric or leather.It can exist during preparing fiber or textile fabric, or then Coating composition is applied to substrate (for example, fiber and/or textile fabric) during such as washing textile fabric.It, can be with after application Such as by under environment temperature or raised temperature dry paint composition by solvent (if any) from Coating material composition It is removed in object.Dry weight based on substrate, the amount for being applied to the treatment compositions of substrate (for example, fiber and textile fabric) are typically enough to The composition of 0.1 weight % to 15 weight %, or the dry weight based on substrate are provided in substrate, are 0.2 weight % to 5 weights Measure the amount of %.
The fiber and textile fabric of available processes compositions-treated include natural fiber, such as cotton, silk, linen and sheep Hair;Regenerated fiber, such as artificial silk and acetic acid esters;Synthetic fibers, such as polyester, polyamide, polyacrylonitrile, polyethylene and poly- third Alkene;Their combination and blend.The form of fiber may include line, long filament, tow, yarn, Woven fabric, woven materials, non- Weaving material, paper and carpet.For the purpose of present patent application, other base can be handled with treatment compositions (including leather) Bottom.It is not wishing to be bound by theory, it is believed that have and conventional hydrophobic siloxanes with the textile fabric that silicone block copolymer is handled Comparable feel, but not apparent adverse effect is generated to the hydrophily of textile fabric.It is not wishing to be bound by theory, it is believed that by upper The coating for stating coating composition formation can have one of following benefit or a variety of: high glaze, flexibility, hardness, scratch-resistant Property and weatherability, ultraviolet light resistant it is exposed or two or more in them.
Embodiment
It now will some embodiments of detailed description of the present invention in the examples below.It is not existing skill referring to embodiment Art, except where so indicated.
Table A-abbreviation
Reference example-is used to prepare the general procedure of copolymer
500ml four-neck flask is placed in temperature control heating block, and loads onto mechanical agitator, thermometer, dropping funel and returns Flow condenser.
1) a) isocyanate compound and b) polysiloxane are added into flask, are mixed to form mixture.
2) stir mixture and at 70 DEG C heat a period of time, then add solvent and the reaction is cooled to 40 DEG C with Under.
3) remaining isocyanate compound is added.
4) by c) chain extender and (optionally) d) crosslinking agent is added in dropping funel together with other solvent, and dropwise It is added in the mixture in flask, a period of time is then heated at 70 DEG C.
5) mixture in flask is cooled to room temperature, and is poured into the deionized water of 2 liters (L).With other The copolymer of water washing precipitating, is collected and is placed in vacuum drying oven, and dry 24 under 75 DEG C and 50 millibars (mbar) Hour.
Sample is prepared using initial substance shown in table 1 and condition according to the program.
The preparation of table 1- copolymer
Table 2 shows the NMR result of the embodiment in table 1 and the molecular weight (Mw) (if applicable) of GPC measurement.Into Row1H-NMR analysis (in terms of ppm, solvent C DCl3) analysis.GPC condition: the THF (1.0ml/min) at 35 DEG C;Column: polymer is real Test 5 μm of mixing-C columns of room PLgel;Detector: 2410 differential refractometer of Waters.
Table 2- copolymer characterization result
Embodiment 1: it is used to prepare the DMS-C16-PU32 copolymer (20% hard segment contents) of adhesion strength test sample Preparation
The copolymer of entitled DMS-C16-PU32 of 5gm is weighed into bottle, and adds the acetic acid second of 5 grams (gm) Ester.Then, the substance is mixed, until all copolymers are dissolved in ethyl acetate, and obtains clear solution.Then, using 20 The mixture is coated to Mylar on piece by the drawdown rod of mil.According to standard pressure sensitive adhesive (PSA) program, lamilate is obtained. Due to all copolymers be 50% ethyl acetate in solution, first at room temperature in vent cabinet in vaporizing coating material Solvent, and it is then in ventilated drying oven that coating is 5 minutes dry at 95 DEG C.It is further covered with LDPE release liner laminated Body, and stand overnight at room temperature.Then the adhesion strength, fissility and cohesive strength of each sample are tested.
When carrying out removing measurement, release liner is fixed in bottom jig, and be coated with the layer of polyurethane of adhesive Zoarium is fixed in top clamp.Fixture is pulled open into 130mm with 10mm/s.The value of each test of report is from coated with bonding Mean force (N)/in of release liner is pulled in the polyurethane laminates of agent.The data from preceding 20mm and last 10mm are abandoned, And the data of remaining 100mm are averaged.Test one to three is measured in parallel to generate report value, and final measurement unit is ox / (linear) inch (N/in).The value of Final Report is the average value (1 inch=~25mm) of 1 to 3 test-strips.
Adhesion strength is measured, release liner is removed from lamilate, wherein lamilate adheres to 1.5in × 9in On the frosted side of (3.8cm × 23cm) polycarbonate item.Using the roller for being coated with 5 pounds of (lb) rubber, by lamilate with 1in/ seconds The rate of (2.5cm/ seconds) is applied on polycarbonate to previous stroke and to the latter stroke.Allow sample and polycarbonate It is kept in contact 30 minutes.Dduring test, polycarbonate is fixed in bottom jig, while lamilate is fixed on top folder In tool.With in peel test, fixture is pulled open into 130mm with 10mm/s.Lamilate (1in wide) is led from polycarbonate The power of drawing is average on 100mm (the preceding 20mm and last 10mm that exclude 130mm drawing), and final measurement unit is newton/(line Property) inch (N/in).The value of Final Report is the average value of 1 to 3 test.
Estimate the amount of the adhesive remained on polycarbonate after testing adhesion strength by visual observation to assess cohesional failure Percentage.In the conceived case, by by adhesive cohesion failure (real cohesional failure) with from polyurethane bottom It is distinguished between the transfer (adhesion failures of bases) of polycarbonate.Any adhesive, which remains on polycarbonate, to be claimed To indicate cohesional failure.These adhesion strength test results are included in table 3.
The preparation of embodiment 2:DMS-C16-PU33 copolymer (20% hard segment contents)
The copolymer of entitled DMS-C16-PU32 (5gm) is weighed into vial, and adds 5gm ethyl acetate.So Afterwards, the content in bottle is mixed on turbine mixer, until all copolymers are dissolved in ethyl acetate, and is clarified Solution.Laminate is prepared, and assesses its adhesion strength, fissility and cohesive strength as in Example 1.
The preparation of embodiment 3:DMS-C16-PU34 copolymer (17.5% hard content)
The DMS-C16-PU34 of 5gm is weighed into vial, and adds 5gm ethyl acetate.Then, in turbine mixer Upper mixing substance until all copolymers are dissolved in ethyl acetate, and obtains clear solution.System as in Example 1 Standby and test laminate.
The preparation of embodiment 4:DMS-C16-PU39 copolymer (17.5% hard content)
The DMS-C16-PU39 of 5gm is weighed into vial, and adds 5gm ethyl acetate.Then, in turbine mixer Upper mixing substance until all copolymers are dissolved in ethyl acetate, and obtains clear solution.System as in Example 1 Standby and test laminate.
The preparation of embodiment 5:DMS-C16-PU40 copolymer (17.5% hard content)
The DMS-C16-PU40 of 5gm is weighed into vial, and adds 5gm ethyl acetate.Then, in turbine mixer Upper mixing substance until all copolymers are dissolved in ethyl acetate, and obtains clear solution.System as in Example 1 Standby and test laminate.
Embodiment 6:DMS-C16-PU23 (36.5% hard content) and DMS-C16-PU33 (20% hard content) are total to Mix formulation
Weigh the 50%DMS-C16-PU23 ethyl acetate solution of the 3gm prepared as described above and the 50%DMS- of 1.5gm C16-PU33 ethyl acetate solution is into vial.Then every kind of solution is mixed on turbine mixer, until being clarified Solution.Then with different ratio mixed solutions as shown in table 4.Preparation and test laminate as in Example 1.
Using the ratio of hard content and soft content in identical copolymer but change preparation, to prepare a series of preparations.By institute There is preparation to be transferred in lamilate, and tests its adhesion strength, fissility and cohesive strength according to the program in embodiment 1.
Table 3: the result of embodiment 1 to 5
Table 4: the result of embodiment 6
The synthesis of embodiment 7- copolymer
Siloxanes-carbamate-urea copolymer sample shown in following table 5 by measuring methanol functionalized poly two Methylsiloxane (C62) is combined with isophorone diisocyanate to prepare.Optionally poly- second of the addition with different molecular weight Glycol (PEG600 and PEG1500).It combines above-mentioned initial substance in flask with methyl isobutyl ketone solvent, and under stiring It is heated to 60 DEG C.Then catalyst (bismuth neodecanoate) is added.Temperature is increased into 80C, and flask contents are heated at 80C 2 hours.Isocyanate content is measured via titration according to DIN EN ISO 11909.
PPG 400 is polypropylene glycol.All organic-the silicone copolymers prepared in embodiment 7 are the clarification in MEK And uniform solution.It is horizontal that remaining NCO is measured according to calculated value.
Embodiment 9- coating
The copolymer prepared in embodiment 7 is prepared in the coating composition, is then hardened with prepares coating.Coating Composition contains the initial substance of amount shown in the following table 6.Coating composition is prepared by mechanical blending initial substance.
Table 6- coating composition
By the coating composition in table 6 on aluminium Q- plate Q36.Film thickness is 100 microns (μm).Before test, By exposing solidification composition filling over 7 days at ambient conditions.Each coating in substrate has smooth and uniform surface.
Contrast sample (" 0 ") is prepared by composition shown in mechanical blending the following table 7.In addition, preparation completely has Machine coating composition, which is used as, refers to (" 00 ").
Table 7- compares coating composition
Composition in table 7 is applied in substrate, and progress as described in above with respect to the composition in table 6 Solidification.Coating composition " 00 " generates transparent and uniform film.Coating " 0 " generates liquid composition heterogeneous, and is applying In addition after, the film surface with many pin holes and pit is formed.This method shows using containing polyurethane-poly organo The composition of alkyl copolymer allows improved coating to be formed, and allows sensitively to enhance siloxanes in these compositions special Property.
Table 8 shows the durability test result of the coating of the composition in table 6.
The test result of coating in 8. table 6 of table
Table 8 is shown, and the repellency with the coating of organic-silicone copolymers preparation as described herein is quicker than organic system Feel higher.Since siloxane unit is chemical bonding, therefore, it is considered that not will do it any flushing in layer aging period.Show that layer has compared with high-flexibility with Clemen value, therefore has during handling paint and during coating aging Lower cracking risk.Clemen test is to measure coating using the tungsten needle being applied on coating under the pressure being increasing Hardness.Rise instruction electrical strength destruction, this again indication coating destruction.This method is ISO 1518.It is applied using being deposited on Water droplet on layer, and using the camera measurement equipped with digital goniometer, to measure water contact angle.It is recorded at T0 and T30 Angle.This meets DIN standard: DIN 55660-2.
It is not wishing to be bound by theory, it is believed that, one or more of following benefit will be presented in the coating prepared as described above: It is improved compatibility, improved weatherability, hydrophobicity, hydrolytic stability, radiation resistance between polyurethane and siloxanes, resistance to Hot, corrosion resistance, surface smoothness and gloss, scratch resistance, the relatively low viscosity under similar solid content (influence volatility Content of organics, VOC) and friction reduction, and if be bonded based on the substance of siloxanes with carbamate backbone chemical (such as in copolymer described herein), instead of by siloxanes mechanical dispersion carbamate in the coating, these benefits It will be more longlasting.

Claims (15)

1. a kind of copolymer compositions, the copolymer compositions include: two or more initial substances, wherein
(I) at least one of described initial substance be copolymer (A) or copolymer (B), wherein
Copolymer (A) is following modular siloxanes-carbamate-urea copolymer:
Wherein
Each RDIt independently is divalent hydrocarbyl mission, divalent halogenated hydrocarbon group;
Each RMIt independently is monovalent hydrocarbon radical or monovalence halogenated hydrocarbon group;
Each RTIt independently is hydrogen or hydrocarbyl group;
Each subscript b is independently 0 to 1,000,000;
Subscript c is 0 to 200,000, and subscript i is 0 to 200,000, and subscript w1 is 0 to 200,000, and subscript w2 is 0 to 200, 000, subscript w3 are 0 to 200,000, and subscript w4 is 0 to 200,000, and quantity (c+i+w1+w2+w3+w4) >=1;
Subscript d is 0 to 1,000,000;
Subscript e is 0 to 1,000,000;
Subscript f is 0 to 1,500,000;
Subscript h >=0;
Subscript j1 >=0;
Each X independently is nitrogen, oxygen or sulphur;
When X is oxygen or sulphur, subscript o=0, and when X is nitrogen, subscript o=1;
Subscript r is 0 to 1,500,000, and quantity f+r >=1;
Subscript s is 0 to 200,000;And
Subscript v is 0 to 200,000;
Subscript y >=0;
And
Copolymer (B) is siloxanes-carbamate-urea copolymer of following formula:
Wherein all symbols and under be marked on A) in defined, and subscript j2 > 0, and if j1 > 0, j2/ j1≥1.1;And
(II) optionally one or both of initial substance (C) and (D), wherein
It (C) is organic polyhydric alcohol;And
It (D) is the reaction product of organic multiple isocyanate and organic polyhydric alcohol.
2. composition according to claim 1, wherein at least two initial substance is selected from:
(A) and (B);
(A) and (C);
(B) and (C);
(A) and (D);
(B) and (D);
(A), (B) and (C);
(A), (B) and (D);
(A), (C) and (D);
(B), (C) and (D);Or
(A), (B), (C) and (D).
3. according to claim 1 or composition as claimed in claim 2, also including (E) organic siloxane polymer.
4. composition according to any one of the preceding claims, wherein there are copolymer (A), and copolymer (A) wraps Formula (I) containing unit:
Wherein each subscript a is independently 0 to 1,000,000;Each subscript b is independently greater than or is equal to 0;Each subscript m >= 0, and subscript n is greater than or equal to 1.
5. composition according to any one of the preceding claims, wherein there are copolymer (B), and copolymer (B) wraps Formula (III) containing unit:
,
Wherein subscript n is greater than or equal to 1, and subscript n 1 is greater than or equal to 0, and subscript n 2 and n3 are 0 or 1, and quantity (n2+n3)= 1。
6. a kind of skin contact adhesive composition, the skin contact adhesive composition includes:
(I) copolymer compositions according to any one of the preceding claims, and
(II) excipient, and
Optionally (III) active constituent.
7. skin contact adhesive composition according to claim 6, wherein the excipient be selected from (II-1) stabilizer, (II-2) binder, (II-3) filler, (II-4) solubilizer, (II-5) skin penetration enhancer, (II-6) adhesion promoter, (II-7) improve two in the reagent or (II-1), (II-2), (II-3), (II-4), (II-5), (II-6) and (II-7) of penetrability The combination of kind or more.
8. according to claim 6 or skin contact adhesive composition as claimed in claim 7, wherein there is (III) described work Property ingredient, and the active constituent is selected from and acts on the drug of central nervous system;Influence the drug of renal function;Influence painstaking effort The drug of pipe function;Influence the drug of gastrointestinal function;For treating the drug of vermination;Antimicrobial, such as silver, patina are closed Object and/or Chlorhexidine;Nutriment;Hormone;Steroids;And for treating dermopathic drug;Non-steroidal anti-inflammatory drugs, such as Salicylate, such as acetylsalicylic acid;Propanoic derivatives, such as (RS) -2- (4- (2- methyl-propyl) phenyl) propionic acid (Bu Luo It is fragrant);Acetogenin, such as 2- { 1- [(4- chlorphenyl) carbonyl] -5- methoxyl group -2- Methyl-1H-indole -3- base } acetic acid (Yin Diindyl U.S. is pungent), enolic acid derivative;Anthranilic acid derivative, cox 2 inhibitor, for example, N- (4- hydroxy phenyl) acetamide N- (4- hydroxy phenyl) acetamide (paracetamol) and sulfonanilide;Local anesthetic, such as containing the part of ester group Anesthetic, for example, 4-aminobenzoic acid ethyl ester (benzocainum);Local anesthetic containing amide group, for example, 2- (diethyl Amino)-N- (2,6- 3,5-dimethylphenyl) acetamide (lidocaine);And natural local anesthetic, such as (1R, 2S, 5R) -2- isopropyl -5- methyl cyclohexanol (menthol).
9. skin contact adhesive composition according to claim 8, wherein the active constituent be selected from antimicrobial, Non-steroidal anti-inflammatory drugs and local anesthetic.
10. use of the skin contact adhesive according to any one of claims 6 to 9 in the application selected from the following terms On the way: the adhesive for medical adhesive tape, the adhesive for wound dressing, the adhesive for prosthese, ostomy appliance bonding Agent, for medical monitor tool adhesive, for scar therapy treatment adhesive, for cosmetics drug paste adhesive with And transdermal drug delivery systems.
11. according to claim 8 or skin contact adhesive as claimed in claim 9 in the application of cosmetics drug paste, scar therapy Using or transdermal drug delivery application in purposes.
12. a kind of coating composition, the coating composition includes:
(a) copolymer compositions according to any one of claim 1 to 5,
(b) coating additive.
13. coating composition according to claim 12, wherein (b) coating additive be selected from (b1) water scavenger, (b2) pigment, (b3) diluent, (b4) filler, (b5) antirust agent, (b6) plasticizer, (b7) thickener, the dispersion of (b8) pigment Agent, (b9) flow aid, (b10) solvent, (b11) adhesion promoter, (b12) catalyst, (b13) have machine aided binder, (b14) siloxanes helps binder, (b15) delustering agent, (b16) levelling agent, (b17) wax, (b18) quenched additive, (b19) anti-scratch Wipe additive, (b20) gloss modified additive, (b21) stabilizer and (b22) crosslinking agent, or (b1), (b2), (b3), (b4)、(b5)、(b6)、(b7)、(b8)、(b9)、(b10)、(b11)、(b12)(b13)、(b14)、(b15)、(b16)、(b17)、 (b18), combination two or more in (b19), (b20), (b21) and (b22).
14. a kind of method, which comprises
I) coating composition described according to claim 12 or claim 13 is applied to substrate, and
Ii the composition is hardened) to form coating.
15. according to the method for claim 14, wherein the substrate includes leather.
CN201780064745.6A 2016-09-19 2017-08-18 Copolymer compositions for coating and adhesive applications Active CN109843380B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662396336P 2016-09-19 2016-09-19
US62/396336 2016-09-19
PCT/US2017/047468 WO2018052646A1 (en) 2016-09-19 2017-08-18 Copolymer composition for coating and adhesive applications

Publications (2)

Publication Number Publication Date
CN109843380A true CN109843380A (en) 2019-06-04
CN109843380B CN109843380B (en) 2021-08-17

Family

ID=59895358

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780064745.6A Active CN109843380B (en) 2016-09-19 2017-08-18 Copolymer compositions for coating and adhesive applications

Country Status (6)

Country Link
US (1) US20210284840A1 (en)
EP (1) EP3515560A1 (en)
JP (1) JP6901552B2 (en)
KR (1) KR102193820B1 (en)
CN (1) CN109843380B (en)
WO (1) WO2018052646A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111388355A (en) * 2020-04-06 2020-07-10 华中科技大学同济医学院附属协和医院 Skin protective agent for preventing pathogen contact and preparation method thereof
CN113026198A (en) * 2019-12-09 2021-06-25 中昊晨光化工研究院有限公司 Functional dressing and preparation method thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD848624S1 (en) * 2016-09-29 2019-05-14 Ethicon, Inc. Release paper for wound treatment devices
CN113518813B (en) * 2019-02-28 2022-10-25 Agc株式会社 Urethane prepolymer, adhesive, attachment material, adhesive tape, wearable device, and wearable device kit
US20230332013A1 (en) * 2020-09-11 2023-10-19 Dow Silicones Corporation Isocyanate-functional prepolymer, composition comprising same, and coating formed therewith

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840796A (en) * 1988-04-22 1989-06-20 Dow Corning Corporation Block copolymer matrix for transdermal drug release
EP0338820A2 (en) * 1988-04-22 1989-10-25 Dow Corning Corporation Heat sealable membrane for transdermal drug release
JPH04292676A (en) * 1991-03-20 1992-10-16 Toyoda Gosei Co Ltd Coating composition
US5756572A (en) * 1995-07-24 1998-05-26 Dow Corning Corporation Silicone pressure sensitive adhesive composition containing thermoplastic multi-segmented copolymer
WO2004055088A1 (en) * 2002-12-17 2004-07-01 Basf Aktiengesellschaft Polyether urethane containing allyl groups
US20040254325A1 (en) * 2003-06-12 2004-12-16 Wacker-Chemie Gmbh Organopolysiloxane/polyurea/polyurethane block copolymers
US20070071700A1 (en) * 2005-09-23 2007-03-29 Anjali Abhimanyu Patil Cosmetic compositions containing silicone/organic copolymers
DE102006056379A1 (en) * 2006-11-29 2008-06-05 Wacker Chemie Ag Siloxane-urea copolymers
CN101321558A (en) * 2005-12-30 2008-12-10 雅芳产品公司 Long wearing cosmetic compositions
EP1588686B1 (en) * 2004-04-23 2010-08-18 Intercos S.p.A. Cosmetic compositions and their use
CN102803423A (en) * 2009-04-17 2012-11-28 3M创新有限公司 Silicone gel adhesive construction

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3384623A (en) 1964-01-11 1968-05-21 Toyo Spinning Co Ltd Production of polyurethane elastomers
DE4121785A1 (en) 1991-07-02 1993-01-07 Bayer Ag METHOD FOR PRODUCING THERMOPLASTIC POLYURETHANE ELASTOMERS
US5998694A (en) 1994-03-02 1999-12-07 Jensen; Ole R. Occlusive dressing with release sheet having extended tabs
DE4437586A1 (en) 1994-10-20 1996-04-25 Basf Schwarzheide Gmbh Process for the preparation of thermoplastic polyurethanes
US6528121B2 (en) 1998-11-19 2003-03-04 Dow Corning Toray Silicone Co., Ltd. Aqueous treatment agent for wiping paper
KR100622332B1 (en) 1999-04-01 2006-09-13 알자 코포레이션 Transdermal drug delivery devices comprising a polyurethane drug reservoir
CN100556929C (en) 2003-10-10 2009-11-04 陶氏康宁公司 The polyurethane composition that contains the silicone resin of carbinol-functional
US20050163978A1 (en) 2004-01-27 2005-07-28 Esben Strobech Article having a surface showing adhesive properties
JP5160217B2 (en) 2004-03-12 2013-03-13 ダウ・コーニング・コーポレイション Method for preparing a silicone pressure sensitive adhesive for supplying hydrophilic drugs using a silicone polyether
WO2007092350A1 (en) 2006-02-02 2007-08-16 H.B. Fuller Licensing & Financing, Inc. Wound care articles, drug delivery systems and methods of using the same
BRPI0601479A (en) 2006-05-03 2007-12-18 Johnson & Johnson Ind Ltda adhesive bandage
WO2008088491A2 (en) 2006-12-20 2008-07-24 Dow Corning Corporation Silicone resin coating compositions containing blocked isocyanates
JP2011500272A (en) 2007-10-23 2011-01-06 ボリンジャー・テクノロジーズ・エル・ピー Thin film wound covering, suction wound treatment system using thin film wound covering, method of using thin film wound covering, and method of manufacturing thin film wound covering
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
JP2013133408A (en) 2011-12-27 2013-07-08 Dow Corning Toray Co Ltd Ordinary temperature-curable coating composition
WO2014116281A1 (en) 2013-01-25 2014-07-31 Patenaude Bart Atraumatic wound care and closure system
GB201320432D0 (en) 2013-11-19 2014-01-01 Scapa Uk Ltd Novel formulation
WO2015100258A1 (en) 2013-12-23 2015-07-02 Dow Corning Corporation Uv-curable silicone compositions and anti-dust coating compositions containing same
GB201323041D0 (en) 2013-12-23 2014-02-12 Dow Corning Curable coating compositions containing an unsaturated alkoxysilane
TWI707932B (en) 2015-02-03 2020-10-21 美商道康寧公司 Hardcoat and related compositions, methods, and articles

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840796A (en) * 1988-04-22 1989-06-20 Dow Corning Corporation Block copolymer matrix for transdermal drug release
EP0338820A2 (en) * 1988-04-22 1989-10-25 Dow Corning Corporation Heat sealable membrane for transdermal drug release
JPH04292676A (en) * 1991-03-20 1992-10-16 Toyoda Gosei Co Ltd Coating composition
US5756572A (en) * 1995-07-24 1998-05-26 Dow Corning Corporation Silicone pressure sensitive adhesive composition containing thermoplastic multi-segmented copolymer
WO2004055088A1 (en) * 2002-12-17 2004-07-01 Basf Aktiengesellschaft Polyether urethane containing allyl groups
US20040254325A1 (en) * 2003-06-12 2004-12-16 Wacker-Chemie Gmbh Organopolysiloxane/polyurea/polyurethane block copolymers
EP1588686B1 (en) * 2004-04-23 2010-08-18 Intercos S.p.A. Cosmetic compositions and their use
US20070071700A1 (en) * 2005-09-23 2007-03-29 Anjali Abhimanyu Patil Cosmetic compositions containing silicone/organic copolymers
CN101321558A (en) * 2005-12-30 2008-12-10 雅芳产品公司 Long wearing cosmetic compositions
DE102006056379A1 (en) * 2006-11-29 2008-06-05 Wacker Chemie Ag Siloxane-urea copolymers
CN102803423A (en) * 2009-04-17 2012-11-28 3M创新有限公司 Silicone gel adhesive construction

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113026198A (en) * 2019-12-09 2021-06-25 中昊晨光化工研究院有限公司 Functional dressing and preparation method thereof
CN111388355A (en) * 2020-04-06 2020-07-10 华中科技大学同济医学院附属协和医院 Skin protective agent for preventing pathogen contact and preparation method thereof

Also Published As

Publication number Publication date
EP3515560A1 (en) 2019-07-31
JP6901552B2 (en) 2021-07-14
WO2018052646A1 (en) 2018-03-22
US20210284840A1 (en) 2021-09-16
CN109843380B (en) 2021-08-17
KR20190047716A (en) 2019-05-08
KR102193820B1 (en) 2020-12-24
JP2019531795A (en) 2019-11-07

Similar Documents

Publication Publication Date Title
CN109843380A (en) The copolymer compositions applied for coating and adhesive
EP3114151B1 (en) Low cytotoxicity switchable adhesive compositions, medical dressings and skin coverings, and methods of treatment using same
US9399123B2 (en) Silicone adhesive compositions
US9017771B2 (en) Gentle to skin adhesive
CN107429029A (en) Removable film forming gel composition and its application process
JP6141868B2 (en) Adhesive article and manufacturing method thereof
WO2018052645A1 (en) Skin contact adhesive and methods for its preparation and use
JP2007532179A (en) Silicone skin adhesive gel
CN105007954B (en) Silicone film
CN115666666A (en) Novel antimicrobial topical skin closure compositions and systems
CN109715692A (en) Skin contact adhesive and its preparation and application
TW202017754A (en) Stretchable film and method for forming stretchable film
CN109890864A (en) Polyurethane-polyorganosiloxane copolymer and the method prepared for it
JP7135782B2 (en) Medical adhesive composition and medical adhesive sheet
CN109337492A (en) Hydrophilic superslide coating and exempt from activate coating catheter
JP2001253819A (en) Adhesive tape for medical use
CA3230379A1 (en) Patch
JP2023142406A (en) Adhesive composition for skin patch, hardened material thereof and adhesive tape for skin patch

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant